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ABSTRACT 
 
Bovine adenovirus type 3 (BAdV-3) is a non-enveloped icosahedral particle which 
contains a double stranded DNA genome. The genome of BAdV-3 is organized into 
early, intermediate and late regions. The late region is organized into seven regions L1-
L7 (Reddy et.al., 1998). The L6 region of late transcription unit of BAdV-3 encodes one 
of the non structural protein named 33K protein. The objective of the present study was 
to characterize the 33K protein and to identify the viral/cellular proteins involved in the 
interaction with 33K protein. 
The RT-PCR analysis revealed the presence of spliced and unsliced mRNAs 
encoding 33K and 22K proteins respectively in BAdV-3 infected cells. The 33K and 22K 
proteins share a N-terminus region of 138 amino acids. To determine the specificity of 
these two proteins, rabbit polyclonal antiserum was raised against peptides representing 
unique C- terminal regions of the proteins. Anti-33Kp serum detected two major proteins 
of 42 kDa and 22 kDa and five minor proteins of 39kDa, 35kDa, 29kDa, 25kDa and 
19kDa in BAdV-3 infected cells or 33K transfected cells. Similarly, anti-22Kp serum 
detected three proteins of 41kDa, 39kDa and 37kDa in BAdV-3 infected cells. However, 
a protein of 39kDa and 37kDa was detected in 22K (having splice sites removed) 
transfected cells. The 33K protein is predominantly localized to the nucleus of BAdV-3 
infected cells and is involved in stimulating the transcription from major late promoter. 
Analysis of mutant 33K proteins demonstrated that amino acids 201-240 and amino acid 
204-231 are required for nuclear localization and MLP transactivation. 
The adenovirus 33K protein appears to be a multifunctional protein performing 
different role in viral infection. Earlier study has shown that the 33K protein plays a role 
in viral capsid assembly and efficient capsid DNA interaction in BAdV-3 (Kulshreshtha 
et.al., 2004). The involvement of 33K protein in different steps of adenovirus replication 
may require protein protein interaction. Using 33K protein as bait in yeast two hybrid 
system, open reading frames (ORFs) of BAdV-3 were screened for the potential 
interactions with 33K protein. The 33K protein showed specific interactions with two late 
viral proteins- 100K and protein V (pV). The yeast two hybrid findings were validated by 
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in vitro binding using in vitro synthesized transcription-translation products. It was 
demonstrated that the interaction of 33K with 100K and pV takes place during BAdV-3 
infection. The stretch of amino acids 81-120 and 161-200 in 33K protein were involved 
in the interaction with pV and 100K protein. 
   For screening the cellular interactions, the 33K protein was used as a bait to 
screen bovine retina cDNA library. The yeast two hybrid screening revealed that the 33K 
protein appears to interact with bovine presenilin-1-associated protein / mitochondrial 
carrier homolog 1 (BoPSAP / BoMtch1) and bovine microtubule associated protein 
(BoMAP). However, subsequent analysis by various in vitro and in vivo assays could 
only confirm the interaction between 33K protein and BoPSAP/BoMtch1.  In addition, 
the 33K protein was also shown to be colocalized with BoPSAP in mitochondria. Based 
on these observations, it may be possible that 33K protein may play an anti-apoptotic by 
interacting with BoPSAP since the human homolog of PSAP has been known to induce 
apoptosis. 
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1.    LITERATURE REVIEW 
The review of literature is divided into three sections: Adenovirus classification, 
Adenovirus biology, protein-protein interactions. 
 
1.1 Adenoviruses 
Adenoviruses were first identified as viral agents by various investigators while 
searching for the etiology of respiratory infections in human beings. These viruses were 
first isolated in human adenoids (tonsils), from which the name is derived. The 
adenoviruses infect membranes of the respiratory tract, intestines and urinary tract of 
humans/animals. Recently, adenoviruses have been shown to be prevalent in coastal 
waters, swimming pool waters, and drinking water (Jiang, 2006). Adenovirus infections 
affect young children and infants more frequently than adults. 
 
1.1.1 Adenovirus classification 
Adenoviruses, members of Adenoviridae family are classified into five genera, 
namely Atadenovirus, Aviadenovirus, Mastadenovirus, Siadenovirus, and unnamed 
genera of adenovirus based on the infecting host range (Benko et al., 2002). Members of 
Atadenovirus genus including bovine adenovirus type (BAdV) -4, ovine adenovirus type 
(OAdV) -7 and egg drop syndrome virus contain AT rich genome. The members of 
Aviadenovirus genus are serologically distinct from the members of other adenovirus 
genera and can only infect birds. Two aviadenovirus, fowl adenovirus type 1 (FAdV)-1 
and (FAdV) -9 genomes represent the longest adenoviral DNA molecules. Recently, 
falcon adenovirus (FalAdV) has been added as a new member to the aviadenovirus genus 
(Oaks et al., 2005). The Mastadenovirus genus which infect mammals includes human 
adenovirus (HAdV) -2 and -5, bovine adenovirus (BAdV) -3, porcine adenovirus 
(PAdV)- 3, equine adenovirus (EAdV)- 2, canine adenovirus (CAdV) -2 and tupaia 
adenovirus (TuAdV). Members of Siadenovirus genus possess a putative sialidase gene 
and comprise of Frog adenovirus (FrAdV) -1 and Turkey adenovirus (TAdV) -3 (Benko 
et al., 2002). Members within each genus show antigenic crossreactivity due to the 
presence of conserved epitopes on the hexons of virus capsids. The DNA sequencing and 
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phylogenetic analysis of moderately conserved region(s) of the hexon gene helps in 
determining adenovirus species and serotype identification (Casas et al., 2005). 
  
1.1.2. Adenovirus biology 
The adenovirus research has contributed to the basic knowledge about DNA 
replication, transcription and translation processes in eukaryotic cells, and has led to the 
discovery of RNA splicing (Thomas and Mathews, 1980). In recent years, interest has 
also been focused on its potential use as a vector for vaccination and gene therapy 
(Russell, 2000). 
 
1.1.2.1 Genome 
   Adenoviruses contain a non-enveloped, double-stranded DNA genome of 26 Kb 
to 45 Kb in length with a G+C content of 33-63% (Davison et al, 2000).  The strand of 
DNA transcribed towards right is called the "r" strand and the strand transcribed towards 
left is called the "l" strand. The genome contains short inverted terminal repeats (ITRs), 
whose length varies among adenoviruses. The ITRs play a major role in adenovirus 
replication. Adenovirus genome contains two identical origins of DNA replication, which 
are localized within the two terminal repeats. The genome also contains cis-acting 
packaging sequences located within several hundred base pairs to the left end. These 
sequences are required for interaction of viral DNA with proteins involved in 
encapsidation (Grable and Hearing, 1992). Adenoviruses are more resistant to UV 
irradiation than RNA viruses since adenoviruses contain double stranded DNA, an 
undamaged DNA strand in adenoviruses can serve as a template for repair by host (Fong 
and Lipp, 2005). 
 
1.1.2.2 Structural proteins 
  The structural proteins are mainly part of the capsid and are essential structural 
components of the virus. The adenovirus genome is surrounded by an icosahedral capsid 
composed of major (hexon, penton, fiber) and minor (pIIIa, pVI, pVIII and pIX)  
structural proteins (Russell, 2000).  In addition to the capsid proteins, there are core 
proteins (V, VII, mu and terminal protein [TP]), which directly bind the viral DNA. 
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1.1.2.3 Non structural proteins 
  Non structural proteins (100K, 33K/22K and 52K/55K) are not the integral part 
of the mature virions (Davison et al., 2000). These proteins are involved in processing of 
precursor virion proteins, and transport and assembly of virion proteins necessary for the 
maturation of viruses. 
 
1.1.3 Virus host interactions 
As a first step in the virus-host interactions, adenovirus requires attachment to the 
cells which is mediated by different cellular receptors. The HAdV-5 attaches the cells via 
coxsackie virus-adenovirus (CAR) receptors (Russell, 2000; Arnberg et al, 2002; Zhang 
and Bergelson, 2005). The HAdV-5 fiber-CAR receptor interaction enables the virus to 
attach to the host cells but is not sufficient for the virus internalization into the cells. The 
entry of the virus into the cells requires penton base interaction with the integrins αvβ3 or 
αvβ5 (Nemerow, 2000). Following these interactions, the HAdV-5 is internalized by 
means of receptor mediated endocytosis in clathrin coated pits and endocytic vesicles 
known as endosomes. The low pH of the endosomes, mainly due to the acidification 
action of proton pumps, leads to the confirmational change in the virus structure and 
subsequent exposure of the hydrophobic domains, which in turn penetrate the endosomal 
membrane and allows the viral particles to escape to the host cytosol. Studies have 
suggested that HAdV-5 entry also requires dynamin (100-kDa cytosolic GTPase, which 
selectively regulates clathrin-mediated endocytosis) as well as activation of several 
signaling molecules including phosphatidylinositol-3-OH kinase (Wang et al., 1998; 
Meier et  al., 2002). These signaling molecules promote endosomal leakage and viral exit 
to the host cytosol. During this stage, the viral capsid is still intact. The HAdV-5 capsids 
then interact with microtubules and dynein motors followed by docking at nuclear pore 
complexes and finally undergo dismantling of the capsid (Kelkar et al., 2004; 2006).  The 
capsid dissociation and nuclear import depends on the ability of L3 protease to degrade 
internal protein VI. The protein pVI acts as cement between the core and outer capsid and 
is shown to shuttle between the cytoplasm and the nucleus (Honkavuori et  al., 2004). 
The HAdV-5 capsid then looses pVIII protein, which is also one of the cementing 
proteins. After complete dismantling, viral DNA along with proteins V and VII enter the 
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nucleus and genes from the early regions (E1, E2, E3, and E4) are transcribed (Matthews 
and Russell, 1998).  
 
1.1.3.1 Early gene expression 
   The HAdV-5 E1A gene is the first viral gene transcribed after the viral DNA 
reaches the nucleus. The E1A transcripts appear within one hour of adenoviral infection. 
The primary E1A transcript is processed by splicing to yield five different messages 
coding for 289R, 243R, 217R, 171R and 55R proteins (Russell, 2000). The E1A proteins, 
especially, 289R and 243R regulate the transcription of viral and cellular genes in the 
adenovirus infected cells. The 289R has additional 46 amino acid region termed as 
“unique region”. Comparison of E1A sequences from various adenovirus serotypes 
identified four conserved regions: CR1, CR2, CR3 (Kimelman et al., 1985) and CR4 
(Avvakumov et al., 2004).  Out of all these regions, CR1 is the most conserved region 
among the currently known protein sequences (Avvakumov et al., 2004). The E1A 
proteins reprogram the host cell gene expression and force the quiescent cells to enter the 
S phase of cell cycle (Frisch and Mymryk, 2002; Berk, 2005; Turnell and Mymryk, 2006; 
Ferrari et al., 2008). These proteins also play a role in transcriptional activation, 
transcriptional repression and productive viral infection in the adenovirus-infected cells 
(Berk, 2005). The E1A alone has been shown to trigger apoptosis (Frisch and Mymryk, 
2002; Berk, 2005) and transform the rodent cells in cooperation with adenovirus E1B 
gene (Berk, 2005; Turnell and Mymryk, 2006). In addition, E1A has been shown to 
repress nitric oxide (an antiviral effector of the innate immune system; Higashimoto et 
al., 2006) production through transcriptional control of the inducible nitric oxide synthase 
(iNOS) gene, allowing the virus to survive in human tissue. 
The HAdV-5 E1B region encodes five proteins (Sieber and Bobner, 2007), which 
are expressed shortly after the E1A protein expression. These proteins inhibit apoptosis 
and thereby sustain the DNA transformation. The E1B-19K protein is expressed early in 
infection and is localized to the membrane of the nuclear envelope (Rao et al., 1997). A 
large amount of E1B-19K protein is shown to be localized in mitochondria and suppress 
the adenovirus induced apoptosis using p53 dependant and p53 independent pathways 
(Lomonosova et al., 2005). E1B-19K is a homologue of Bcl-2 since these proteins show -
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40 % amino-acid sequence homology (Chiou et al., 1994).  The E1B-55K protein 
regulates the selective export of viral mRNAs from the nucleus to the cytoplasm and 
translation of viral mRNAs (Dobbelstein et al., 1997; Gonzalez et al., 2006). 
The E2 region is one of the most important regions for successful completion of 
HAdV-5 replication as it encodes the proteins essential for adenoviral DNA replication. 
Two major types of transcripts, E2A and E2B arise from the E2 region. The mRNA 
coding for DNA-binding protein (DBP) arises from the E2A region (Stillman et al., 
1981). DBP is a 72 kDa protein that contains a highly phosphorylated N-terminal protein 
and highly conserved non-phosphorylated C-terminal domains (Linne and Philipson, 
1980). The N-terminal domain of DBP has phosphorylated serine and threonine residues, 
and is essential for viral DNA replication. The C-terminal domain of DBP is involved in 
DNA binding, initiation and elongation phases of DNA replication, and transcriptional 
control of the major late promoter (MLP).  DBP enhances the rate of initiation of 
adenoviral DNA replication by stimulating the binding of viral DNA polymerase to 
double stranded DNA (Van Breukelen et al., 2003).  The mRNAs coding for the 
precursor terminal protein (pTP) and DNA polymerase (pol) arise from the E2B region. 
The pTP is a 75 kDa protein, which forms a heterodimer with the 140 kDa DNA 
polymerase. The pTP-pol complex is capable of initiating viral DNA replication and is 
enhanced by the host proteins like Oct-1 (de Jong et al., 2003; Mysiak et al., 2004).  This 
complex shows reduced polymerase and exonuclease activity as compared to free 
adenovirus polymerase, which may be due to the binding of pTP at the primer binding 
groove of the adenovirus polymerase (Brenkman et al., 2002). This heterodimer is 
transported to the nucleus of infected cells due to the presence of a nuclear localization 
signal in pTP and attaches to the nuclear matrix (Fredman and Engler, 1993).  
The HAdV-5 E3 region transcribes nine mRNAs generated by alternative splicing 
of the common transcript that initiates from the E3 promoter. The E3 promoter has two 
binding sites for NF-kB, which drives most of the E3 transcription in activated T cells 
(Williams et al., 1990). The E3 promoter has been shown to be upregulated in activated 
T-cells in an E1A independent manner for the efficient production of anti-apoptotic 
proteins (Mahr et al., 2003). The E3 region encodes gp19, 14.7K, 14.5K, 12.5K, 10.4K, 
11.6K and 6.7K (Tollefson et al.,1996). The E3 proteins are also called as stealth proteins 
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since these proteins appear to reduce the recognition of the adenovirus infected cells by 
innate and adaptive arms of the immune system (Toth et al., 2005). 
The gp19 protein is the predominant protein in the E3 region and is retained in the 
rough endoplasmic reticulum. It binds to major histocompatibility (MHC) class I antigens 
in the rough endoplasmic reticulum, thereby prevent their transport to the cell surface and 
cell lysis by adenovirus - specific cytotoxic T lymphocytes. (Rawle et al., 1989). This 
protein also decreases the amount of peptides presented on MHC class I due to inhibition 
of peptides processing by tapasin (Horwitz, 2004) but does not block the binding of 
peptides to MHC class I (Liu et al., 2005). Tapasin is a transmembrane glycoprotein 
located in the endoplasmic reticulum. The E3-14.7K protein inhibits TNF-mediated 
apoptosis (Horton et al., 1991). The TNF induced apoptosis is initiated by ligand-induced 
recruitment of TNF receptor associated death domain (TRADD) and Fas-associated death 
domain (FADD) to the death domain of TNF receptor 1 (TNFR1), forming death-
inducing signaling complex (DISC). The 14.7K protein inhibits apoptosis by inhibiting 
TNF induced death-inducing signaling complex (DISC) (Schneider-Brachert et al., 2006). 
In addition, the 14.7K protein inhibits the antiviral immunity and inflammation by 
inhibiting the NF-KB transcriptional activity caused by TNF mediated receptor signaling 
(Carmody et al., 2006). The E3 11.6K protein or ADP (adenovirus death protein) 
promotes the killing and lysis of adenovirus infected cells by caspase dependant and 
caspase independent mechanisms (Zou et al., 2004), thereby helps in the spread of virus 
(Tollefson et al., 1996; Doronin et al., 2003). Currently this property of ADP is being 
exploited in designing oncolytic adenovirus vectors used in cancer gene therapy (Toth et 
al., 2004; Yun et al., 2005). The role ADP can be compensated by abolishing the function 
of E1B-19K since ADP plays an opposite role to that of E1B-19K, which inhibits 
apoptosis (Subramanian et al., 2006).  The E3-10.4K (RIDalpha) and E3-14.5K 
(RIDbeta) proteins form a heterotrimer known as the RID (receptor internalization and 
degradation) complex that localizes to the plasma membrane (Stewart et al., 1995). These 
proteins are transmembrane proteins and are post-translationally modified. The 
adenovirus RID complex modulates the immune response by decreasing the expression 
of surface levels of tumour necrosis factor receptor 1 (TNFR1), inhibiting the activation 
of NF-kB, thereby creating a environment favorable for the survival of the virus (Fessler 
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et al., 2004; Chin and Horwitz, 2006). In addition, RID complex inhibits the LPS 
mediated inflammation by inhibiting IL-1R and TLR4 (Toll-like receptor 4) signaling 
and activation of NF-kB (Delgado-Lopez and Horwitz, 2006). The E3-6.7K protein is a 
small integral membrane protein having three N-glycosylation sites. Of these three sites, 
one site is modified with high-mannose oligosaccharides, which suggest that this protein 
is localized to the endoplasmic reticulum (Wilson-Rawls and Wold, 1993; Moise et al., 
2004). The E3-6.7K protein along with RID complex downregulates TNF-related 
apoptosis-inducing ligand (TRAIL) receptor 2 thereby shows the anti-apoptotic property 
(Lichtenstein et al., 2004). The E3-12.5K protein is synthesized in early stages of 
infection and its function is not known (Hawkins and Wold, 1992). 
The E4 transcription unit is localized at the right end of the genome. The HAdV-5 
E4 promoter generates a primary transcript, which undergoes alternative splicing to 
produce at least 18 distinct mRNAs encoding seven different polypeptide products. Six of 
these polypeptides are known to exist in the adenovirus infected cells (Weitzman, 2005). 
The E4 gene products play a role in viral DNA replication, late protein synthesis, early to 
late switch in adenoviral infection and target regulators of cell signaling contributing to 
the cell transformation and oncogenicity (Tauber and Dobner, 2001).  
The E4 ORF1 is conserved among all HAdVs and contributes to the oncogenecity 
of adenovirus (Latorre et al., 2005). The E4 ORF1 mRNA accumulates in the cytoplasm 
following the adenovirus infection due to formation of E1B-55K/E4ORF6 complex (Dix 
and Leppard, 1993). The E4 ORF3 is a highly conserved protein, which is associated 
with nuclear matrix causing alterations in the architecture of nucleus (Doucas et al., 
1996). It is involved in viral DNA replication, late viral protein synthesis, host protein 
synthesis shut off, accumulation of misfolded protein in the aggresomes (cytoplasmic 
structures) and inactivation of MRN complex preventing the concatemer formation 
resulting in viral DNA replication (Araujo et  al., 2005; Hart et  al., 2006). The MRN 
complexes comprise of cellular proteins MRE11, RAD50, and NBS1 required for DNA 
double-strand break repair and for binding to DNA ends. The E4 ORF4 is also highly 
conserved among all the adenoviruses and is not essential for the virus growth (Halbert et 
al., 1985). It plays an important role in regulating viral replication and splicing of late 
adenoviral mRNAs (Bridge et al., 1993; Kanopka et al., 1998). The E4 ORF6 encodes a 
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34 kDa protein, which has several cysteine and histidine residues that form a functional 
zinc binding domain (Boyer and Ketner, 2000). The E4 ORF6 shows oncogenic potential 
in cooperation with E1B and blocks p53 mediated transcriptional activity (Dobner et al., 
1996). In addition, it plays an important role in viral DNA replication, host protein 
synthesis shutdown and nucleocytoplasmic transport of late viral mRNA. 
 
1.1.3.2 DNA replication 
  The HAdV-5 genome contains cis-acting DNA sequence within ITRs, which is 
known as origin (Ori) of DNA replication (Coenjaerts et al., 1994). In addition, there are 
auxillary regions, which enhance the rate of DNA replication up to 200 fold in vivo and 
in vitro. The replication initiation occurs by a protein priming mechanism in which pTP 
binds the first nucleotide of the nascent strand, a dCMP residue, covalently through a Ser-
dCMP phosphodiester bond. The pTP, pol and DBP together with the core origin initiate 
a low level of replication (de Jong et al., 2003; Mysiak et al., 2004). After the formation 
of the pTP-dCMP complex, elongation starts by strand displacement mechanism. 
Elongation is rapid and requires DBP and polymerase. Later, the displaced strand can 
duplicate either by the formation of a panhandle structure, which regenerates at the origin 
or by the intermolecular renaturation of opposite strands originating from the use of the 
origins at both ends (Wang and Pearson, 1985). The cellular factors NF1 and NFIII/Oct1 
along with these viral proteins form a stabilized nucleoprotein structure at the origin 
resulting in enhancing the rate of the reaction (Wang and Pearson, 1985).  
 
1.1.3.3 Intermediate gene expression 
   Intermediate genes are expressed at the time of viral DNA synthesis. The two 
genes encoding pIX and IVa2 proteins form the structural components of the HAdV-5 
virion and have been shown to activate the major late promoter (Lutz et al., 1997). The 
pIX is a 140 amino acid protein which contain a conserved (among adenovirus pIX) 
amino-terminal domain, a central alanine-rich domain, and a conserved carboxy-terminal 
domain (Rosa-Calatrava et al., 2001). Each virion capsid has 240 molecules of pIX 
(Parks, 2005).  Deletion of pIX results in the production of heat labile, adenovirus virions 
suggesting that pIX confers stability to viral capsid (Vellinga et al., 2005). The C-
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terminal domain of pIX contains a leucine repeat region, which is involved in 
trimerization. The trimerization of pIX is not essential for its inclusion in the adenoviral 
capsid (Rosa-Calatrava et al., 2001). The C-terminal domain of pIX acts as a 
transcriptional activator and can reorganize the nuclear proteins (ND10 domains; Parks, 
2005). The C-terminus of pIX is exposed on the surface of the mature virion and can be 
used for the addition of targeting ligands. By exploiting this property of pIX, 
adenoviruses are able to infect many cell types which are not normally infected by wild -
type adenovirus (Dmitriev et al., 2002; Li et al., 2005).  
The HAdV-5 IVa2 is a 450 amino acid protein localized in the nucleoplasm and 
nucleolus of virus infected cells (Lutz et al., 1996). It acts as a transcriptional activator of 
the major late promoter (Tribouley et al., 1997; Pardo-Mateos and Young, 2004) and 
plays a role in viral DNA packaging (Zhang et al., 2001; Ostapchuk et al., 2005), and 
virus assembly (Zhang and Imperiale, 2003; Perez-Romero et al.,  2005; Christensen et 
al., 2008). The cellular protein IVa2-RF binds specifically to IVa2 promoter and 
represses the transcription from the IVa2 promoter (Iftode and Flint, 2004). Creation of 
mutations in the IVa2 promoter impairs the binding of IVa2-RF factor to the promoter, 
resulting in more efficient IVa2 transcription and efficient viral DNA synthesis (Iftode 
and Flint, 2004).  
 
1.1.3.4 Late gene expression 
   Following the onset of viral DNA replication, the transcription pattern changes 
from early to late phase. The late phase is characterized by the establishment of late 
transcription program, reduction in the early gene expression, inhibition of host cell cap-
dependent translation and commencement of viral assembly. All these events depend on 
the expression of the major late transcription unit (MLTU), which is controlled by the 
major late promoter (MLP) (Thomas and Mathews, 1980). In HAdV-5, the MLTU 
generates a primary transcript that is subsequently processed into more than 20 different 
mRNAs, which are further divided into five families L1-L5 (Thomas and Mathews, 
1980). Each family consists of multiple alternatively spliced mRNAs with a common 
poly A site. Each mature mRNA contains a common set of three short 5` leader segments 
called tripartite leader (TPL) sequences (Chow et al., 1977). The TPL enhances the 
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translation of viral mRNA in infected and transfected cells (Huang and Flint, 1998).  
The L1 region of HAdV-5 encodes two proteins 52K/55K and IIIa, which have a 
common polyA signal. The 52K/55K proteins are differentially phosphorylated forms of 
a single 48kDa polypeptide, which are localized to the nucleus of the infected cells 
(Lucher et al., 1986). Both of these isoforms have been shown to be present in the virus 
assembly intermediates but not within the mature virions. 52/55-kDa regulates 
transcription from the major late promoter (Gustin et al., 1996). In addition, it plays an 
important role in the viral DNA encapsidation and assembly (Hasson et al., 1989; Perez-
Romero et al., 2005, 2006; Wohl and Hearing, 2008), as it is required for the stable 
association between viral DNA and empty capsid (Gustin and Imperiale, 1998). These 
proteins are localized to the regions of the nucleus different from viral DNA replication 
centers, suggesting that replication and assembly of adenovirus occur in separate nuclear 
compartments (Hasson et al, 1992). Another L1 protein, IIIa protein, is a 64 kDa viral 
phosphoprotein, which is generated by the cleavage of pIIIa at the N-terminus during 
maturation of the virus (Vellinga et al., 2005). It is shown to be located underneath the 
vertex region (San Martin et al., 2008).  The protein IIIa is involved in the virus assembly 
(Chroboczek et al., 1986; San Martin et al., 2008) and is capable of enhancing its own 
synthesis using an autostimulatory system by reducing the 52K/55K expression (Molin et 
al., 2002; Tormanen et al., 2006; Vellinga et al., 2005). 
The L2 region encodes pIII, pV, pVII and mu proteins. The pIII protein is a 
penton base protein, which plays an important role in the entry of the adenovirus by 
binding of RGD (Arg-Gly-Asp) motifs present in the penton base to the cell surface 
integrins thus stimulating receptor-mediated endocytosis and endosomal penetration 
(Vellinga et al., 2005; Rentsendorj et al., 2006). Deletion of penton base RGD motifs 
affects the efficiency of internalization and the endosomal escape of viral particles 
(Shayakhmetov et al., 2005). The pV protein is a 50 kDa protein and forms a link 
between the viral DNA-protein complex and inside of the adenovirus capsid (Matthews 
and Russell, 1998). This protein plays a role in the delivery of viral DNA to the host cell 
during the infection process and associates with infected cell nucleoli during the virus life 
cycle. It contains multiple nuclear and nucleolar targeting signals and is capable of 
redistributing the major nucleolar protein, nucleolin from nucleus to cytoplasm 
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(Matthews, 2001).  It is not essential for adenovirus viability and plays a role in the 
correct assembly of the infectious viral particles (Ugai et al., 2006). The pVII protein is a 
19.2 kDa major core protein accounting for 10% of the protein mass of the virion. The 
protein VII is localized to the nucleus of the infected cells, which is mediated by the 
cellular nuclear import receptors like importin alpha, importin beta (Wodrich et al., 
2006). It is associated with the viral DNA during the early phase of infection and 
mediates transcriptional repression in the nucleus before E1A expression. Following the 
expression of E1A, there is a decrease in protein VII mediated repression, resulting in the 
onset of transcription (Johnson et al., 2004). The pVII plays a role in remodeling of the 
adenovirus chromatin and stimulates transcription and replication of adenovirus in vitro 
(Gyurcsik et al., 2006). It also plays a role in packaging of viral DNA (Zhang and Arcos, 
2005). The protein Mu is an 11 kDa protein, which binds to viral DNA and plays a role in 
viral chromosome condensation (Anderson et al., 1989; Keller et al., 2002). The 
precursor form of Mu is localized to the nucleolus and modulates the expression of E2 
proteins (Lee et al., 2004). The proteolytic processing of pre Mu at amino acid positions 
31 and 50 by adenovirus protease generates three fragments (Lee et al., 2004). The central 
polypeptide fragment is subsequently incorporated in the virions. The C-terminal pre-Mu 
is essential for the repression of the pVI (late protein) expression in adenovirus-infected 
cells while the function of the precursor's N-terminal peptide in infected cells is not clear 
(Lee et al., 2004). 
The L3 region encodes three proteins namely protein VI, hexon, and a 23kd 
proteinase. The VI is a 22 kDa protein generated by cleavage from its precursor pVI and 
is located in the capsid adjacent to the hexon (Greber et al., 1993). The pVI contains two 
nuclear-localization sequences (NLS) and two nuclear-export sequences (NES), which 
are removed upon proteolysis during virus maturation (Vellinga et al., 2005). It is 
responsible for the transport of hexon capsomeres to the nucleus (Matthews and Russell, 
1995) and helps the virus particle to escape from the endosome (Wiethoff et al., 2005). 
The 23 kDa proteinase is a protein needed for proteolytic cleavage of some adenovirus 
proteins during maturation of the virus. This protein has also been shown to possess 
deubiquitinating activity, which interferes with various cellular processes like 
transcription and intracellular signaling, and conferring the advantage to the adenovirus 
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replication (Balakriev et al., 2002). Another L3 protein, hexon, is the most abundant 
capsid protein present in adenoviruses. The hexon is a trimeric protein, which comprises 
of three identical tightly associated molecules (Rux and Burnett, 2000).  Structural and 
genetic analysis revealed that the hexon protein contains two loop structures, seven 
hypervariable regions (HVR) and type-specific residues. The loop 1 of the hexon protein 
contains HVR-1 to HVR-6 and loop 2 contains HVR-7, which is associated with type 
specific determinants (Wu et al., 2005). The hexon surface loops show the highest 
antigenic variability among adenoviruses and contain most of the type specific epitopes. 
(Rux and Burnett, 2000). Significant differences in the epitopes are present in the hexon 
hypervariable regions between chimpanzee adenovirus and other known adenoviruses 
(Farina et al., 2001). Modification of the hexon by mutating asparagine residues to 
leucine has been shown to increase the adenovirus under different conditions (Blanche et 
al., 2001). As hexon is involved in the nuclear delivery of infectious virus, it can be 
exploited for enhancing the nuclear targeting of synthetic systems (Carlisle, 2002). In 
addition, the hexon protein has been shown to have an adjuvant effect, which is exerted 
by the disrupted adenovirus particles in response to the immunogen (Molinier et al., 
2002).                       
The L4 region encodes three non-structural proteins- pVIII, 100K and 33K/22K 
polypeptides. The pVIII a 15 kDa protein, is one of the hexon-associated proteins, which 
connects the core with the inner surface of the adenovirus capsid (Liu et al., 1985). It is 
found in empty capsids and not in purified virus preparations (Vellekamp et al., 2001). It 
plays a role in the virions structural stability (Liu et al., 1985). 
The 100K protein plays an important role in various aspects of the adenovirus life 
cycle. It has been shown to be involved in the transport of newly synthesized hexon 
monomers from the cytoplasm to the nucleus and trimerization of hexon monomers 
(Cepko and Sharp, 1983; Gambke and Deppert, 1981; Hong et al., 2005). The arginine 
methylation in 100K protein contributes to its localization to nucleus and plays an 
important role in productive infection (Iacovides et al., 2007). This protein appears to act 
as a scaffolding protein required for the assembly of adenoviral capsids (Morin and 
Boulanger, 1986). Deletion of the gene encoding the 100K protein results in reduction of 
hepatotoxicity caused by adenoviral vectors (Hodges et al., 2001). In addition, the 100K 
 13
protein interacts with a number of RNA transcripts preferentially allowing the translation 
of adenovirus derived late transcripts (Riley and Flint, 1993). The 100K protein initiates 
the translation of adenoviral mRNAs by ribosome shunting (Cuesta et al, 2004; Xi et al., 
2004) in a tyrosine phosphorylation-dependent manner (Xi et al., 2005). The 100K 
protein has also been shown to be a Granzyme B (GrB) substrate that prevents cytotoxic 
lymphocyte granule-induced apoptosis in infected target cells by potently inhibiting GrB 
(Andrade et al., 2001, 2007). Granzyme B is a cytotoxic lymphocyte granule protease 
that plays a critical role in mediating cytotoxicity. 
The 33K protein is a phosphoprotein predominantly localized in the nucleus of 
infected cells (Gambke and Deppert, 1981; Oosterom-Dragon and Anderson, 1983). The 
gene encoding the 33K protein is unique among the genes transcribed from the MLP in 
that it contains a 202-nt intron (Oosterom-Dragon and Anderson, 1983). The 33K protein 
contains a long stretch of acidic amino acids (aa 15 to 34) at the N- terminus, splicing 
enhancer domain at the C-terminus and a central region with two alanine stretches serving 
as hinge region separating two protein domains (Tormanen et al, 2006).  The 33K protein 
has a molecular weight of 39 kDa, which is higher than expected due to presence of high 
proline and glutamic acid content (Oosterom-Dragon and Anderson, 1983). The 33K 
protein has been shown to switch from early to late mRNA transcription from MLP 
(Farley et al, 2004). Studies have suggested that the 33K protein plays a role in viral 
assembly (Fessler and Young, 1999; Finnen et al., 2001). In addition, this protein acts as 
a virus encoded RNA splicing factor, which selectively enhances the splicing of 
transcripts with weak 3’ splice site (Tormanen et al., 2006; Akusjarvi et al., 2008). It is 
maximally expressed at the beginning of the late phase of infection and binds in the 
presence of IVa2 protein to intragenic sequences of the MLP essential for late phase of 
transcription (Ali et al., 2007). Another L4 protein, the 22K protein shares N-terminal 
105 amino acids with 33K protein and plays a role in adenoviral DNA encapsidation 
(Ostapchuk et al., 2006). 
The L5 region encodes the structural protein fiber (Ruigrok et al., 1990). The fiber 
is a long trimeric structure extending from twelve vertices of the adenovirus capsid. It is 
comprised of conserved N-terminal tail, which is embedded in the penton base, a shaft 
that is made of repeating units and a C-terminal head that is involved in the initial 
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attachment of the virus to the cellular receptor.  The shaft provides rigidity to the fiber 
and is composed of a number of 15 amino-acid repeats, which determine the length of the 
shaft (Ruigrok et al., 1990). These repeats are rich in proline and glycine residues, which 
are pivotal for the proper folding of the shaft. The length of the shaft plays an important 
role in determining the adenovirus tropism (Ambriovic-Ristov et al., 2003). The C-
terminal head forms the knob region, which starts from the conserved motif TWLT 
(Chroboczek et al., 1995) and mediates the attachment to the cellular receptor (Devaux et 
al., 1990). This variability is responsible for the antigenic diversity among the adenovirus 
serotypes. The knob contains a stabilization element for fiber trimerization and plays an 
important role in fiber protein synthesis (Henning et al., 2006; Li et al., 2006) 
 
1.1.3.5 Virus assembly and release 
During the late phase of infection, adenovirus structural and non-structural 
proteins are synthesized. These proteins are rapidly transported to the nucleus where the 
assembly process begins. The first step in the adenoviral assembly is formation of 
capsomers, which are the major structural units of the capsid assembled from monomeric 
polypeptide chains. This process requires 100K protein, which acts as a scaffolding 
protein (Hodges et al., 2001). During viral assembly, intermediate stages (light and heavy 
intermediate) are observed, which contains some viral proteins which are normally absent 
in mature virions. The light intermediates become heavy intermediates after the release of 
the scaffolding proteins including the 100K and 33K proteins, and association with viral 
DNA (Hodges et al., 2001; Finnen et al., 2001).  The assembly begins with formation of 
empty capsids and subsequent entry of the viral DNA into the preformed capsids. A cis-
acting DNA sequence located within the left end of viral DNA, mediates DNA-capsid 
interaction (Russell, 2000). Therefore, the encapsidation starts from the left end of the 
viral DNA. It is anticipated that one or more proteins bind at the packaging sequence, 
thereby mediating the interaction of viral DNA with the capsid. The next step of 
maturation involves the formation of young virions where several polypeptides like pIIIa, 
pTP, pVI, pVII, pVIII are in precursor form and are cleaved during the maturation phase 
by proteinase to generate mature IIIa, TP, VI, VII, VIII proteins (Russell, 2000). This 
process of cleavage stabilizes the structure of the particle and renders it infectious. The 
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mature virions remain in the infected cells and are released upon cell lysis. 
 
1.1.4 Protein protein interactions 
Proteins play an important role in carrying out the biological activities of the cell. 
Because of their different structures, proteins interact with other proteins in complicated 
ways. Thus, protein-protein interactions refer to the association of the proteins and their 
study with a biochemical point of view.  These interactions can be either permanent or 
transient. The permanent interactions exist in complex forms and are stable. The transient 
interactions are not stable as in these interactions proteins associate and dissociates in 
vivo. A few interactions are transient in vivo but later on become permanent due to 
changes in cellular conditions (Nooren and Thornton, 2003). In the life cycle of 
adenoviruses, protein-protein interactions play an important role in viral entry, DNA 
replication, transcription and cell cycle control.  
Adenoviruses are exploited as a model to study the virus-host interactions and to 
identify the cellular molecular mechanisms (Russell et al., 2004; O’Shea, 2005). During 
the adenovirus infection, there is a reprogramming of host cells to establish conditions 
favorable for replication to ensure efficient production of progeny virus. For achieving 
this goal, adenovirus encodes several proteins, which interact with other viral and cellular 
proteins resulting in inactivating the cellular DNA machinery. 
As a part of the virus-host cell interaction, multiple receptor binding is required 
for gaining the entry of virus to the cells. In HAdV-5, the fiber and penton base interacts 
with CAR receptors and integrins respectively, leading to the entry of virus into cells 
(Nemerow, 2000). The flexibility of fiber is important for the efficient interaction of fiber 
with CAR receptors (Wu et al., 2003). In addition, the interaction of adenovirus fiber 
knob with cellular receptors determines the intracellular trafficking route of the 
adenoviruses (Shayakhmetov et al., 2003). The intracellular trafficking of HAdV-5 and 
HAdV-5/35 viruses (HAdV-5 based vector containing sequences encoding the HAdV-35 
fiber knob domain instead of the HAdV-5 knob) varies since HAdV-5/35 virus is found 
in late endosomes/lysosomes upto 4 hours after infection, whereas HAdV-5 escapes to 
the cytosol and is not colocalized with late endosomes/lysosomes (Shayakhmetov et al., 
2003).   
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1.1.4.1 Interactions during early gene expression 
The E1A proteins of adenoviruses reprogram cellular gene expression by 
interacting with various regulatory proteins (Frisch and Mymryk, 2002). These proteins 
exhibit a wide range of biological interactions involving transcriptional activation and 
transcriptional repression. Since the E1A proteins do not bind to DNA with any sequence 
specificity, they trans-activate by binding to the factors regulating transcription. So far 
conserved regions named critical region (CR) 1 to (CR) 4 have been identified in E1A 
protein of HAdV-5 (Avvakumov et al., 2004). 
The CR3 region of E1A interacts with both basal factors (e.g. TATA-binding 
protein [TBP]) as well as transcription factors (e.g. ATF, c-Jun, Sp1, upstream 
stimulatory factor [USF], CCAAT box binding factor, and Oct 4) (Berk, 2005).  The CR3 
region consists of C- terminal domain and N- terminal domain.  The C- terminal domain 
of CR3 region interacts with DNA binding domain of transcription factors that binds to 
adenovirus early promoters (Berk, 2005). The N- terminal domain of CR3 (functions as 
the activation domain) region, binds to full form of TBP (TBP) and activates the 
transcription by stimulating the formation of a multiprotein transcription initiation 
complex by RNA polymerase II (Berk, 2005). The transactivation capacity of CR3 region 
is directly proportional to the binding ability of E1A to MED23, a component of 
transcriptional mediator (Berk, 2005). 
  The interaction of HAdV-5 E1A protein (through Leu-X-Cys-X-Glu motif) with 
the pocket domain of RB proteins (Felsani et al., 2006), activates cyclin kinases (Cdk4 
and Cdk6), which triggers pRB phosphorylation, leading to the release of E2F. The E2F, 
in turn, functions as a transcriptional activator and induces a large number of cellular 
genes. This displacement of RB proteins from E2Fs drive the cells from G0 phase to S 
phase of cell cycle leading to the immortalization of the primary cells. In addition, the 
E1A stabilizes the expression of p53 by interacting with Mdm4, a p53-binding protein (Li 
et al., 2004).  
The interaction of adenovirus E1A protein with some cellular proteins helps to 
repress the transcription of many genes involved in the regulation of growth and 
differentiation. The N-terminus of HAdV-5 E1A protein binds to the protein complex 
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p300/CBP involved in the chromatin structure (Loewenstein et al., 2006). The p300/CBP 
complex possesses histone acetyltransferase activity (HAT), which promotes the 
destabilization of histone-DNA interactions, resulting in the increased accessibility of the 
chromatin to the transcription factors. The binding of E1A to the p300/CBP complex 
inhibits the function of histone acetyltransferase activity and thereby represses the 
transcriptional activity (Frisch and Mymryk, 2002). The E1A-p300 interaction also 
modulates the expression of cellular genes promoting apoptosis and reduces the tumor 
cell metastasis (Miura et al., 2006).  
The HAdV-5 E1A also interacts with the cellular proteins like p400 and TRRAP 
(factors regulating gene transcription by affecting chromatin organization) and causes the 
epidermal growth factor receptor (EGFR) suppression resulting in apoptosis (Fuchs et al., 
2001; Flinterman et al., 2007). The interaction of E1A proteins with corepressors like C-
terminal-binding protein (CtBP) is required for the optimal infectivity of adenovirus as 
the E1A-CtBP complex represses the cellular genes by interacting with their promoter 
regions. (Chinnadurai, 2002; Zhao et al., 2006; Bruton et al., 2008).  In the absence of 
E1A-CtBP interaction, the expression of early viral proteins is decreased (Zhao et al., 
2006). 
The HAdV-5 E1B-19K protein protect the cells from TNF-induced apoptosis 
during viral infection (Chiou et al., 1994). It interacts with pro-apoptotic cellular proteins 
namely Bax and Bak, and blocks the apoptosis by inhibiting mitochondrial pore 
formation and caspase activation (Sundararajan et al., 2001; Sundararajan and White, 
2001; Berk, 2005). The E1B 156R protein interacts with cellular apoptosos regulator 
protein Daxx suggesting its role in cell transformation (Sieber and Dobner, 2007).  
The HAdV-5 E1B-55K protein counteracts the apoptotic functions of E1A by 
interacting with N-terminus of p53 (Kao et al., 1990), resulting in SUMOylation of p53 
(Muller and Dobner, 2008). These interactions maintain the cells in transformed stage 
(Martin and Berk, 1998; Liu et al., 2000; Roth and Dobbelstein, 2003; Schwartz et  al., 
2008).  In addition, the E1B-55K also interacts with E4-ORF6 resulting in the selective 
export of viral mRNAs from the nucleus and their translation in cytoplasm (Dobbelstein 
et al., 1997; Gonzalez et al., 2006). Another E1B protein, E1B 156R, promotes the cell 
transformation independent of repression of p53 mediated transcriptional activation. It 
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contains a transcriptional repression domain which interacts with the cellular apoptosis 
regulator Daxx, suggesting its role in cell transformation (Sieber and Dobner, 2007).  
The HAdV-5 E2 proteins play a role in adenoviral replication by interacting with 
other proteins. The DBP interacts with SrCap (potent activator of transcription mediated 
by CBP and CREB) and inhibits the transcription mediated by the carboxyl-terminal 
region of SrCap (Xu et al., 2003). Another E2 protein, pTP forms a complex with pol 
(DNA polymerase) and attaches to core region of adenoviral ITR to initiate the viral 
replication. The viral replication is augmented by the interaction of cellular factors like 
Nuclear Factor 1(NF1) and Oct1 with the auxillary region of adenoviral ITR (Coenjaerts 
et al., 1994). 
The HAdV-5 E3 proteins are known to evade host antiviral immunity. The E3-
14.7K protein inhibits antiviral immunity and inflammation by inhibiting NF-kB activity. 
It interacts with the p50 homodimer (NF-κB family of transcription factor) and blocks the 
p50 homodimer DNA binding resulting in an anti-inflammatory action (Carmody et al., 
2006). Another E3 11.6K protein, known as adenovirus death protein (ADP), promotes 
the lysis of adenovirus infected cells, thereby helps in the spread of virus (Tollefson et al., 
1996). The ADP interacts with MAD2B resulting in the cell lysis and release of the virus 
(Ying and Wold, 2003). The MAD2B is a member of MAD (mitotic arrest deficiency) 
family, involved in the mitotic checkpoint control mechanism (Ying and Wold, 2003).   
The HAdV-5 E4 proteins interact with regulators of cell signaling thereby 
contributing to the cell transformation by adenovirus. The E4 ORF1 targets a family of 
cellular proteins which play a role in cell signaling and signal transduction (Tauber and 
Dobner, 2001). The E4 ORF1 has a PDZ domain binding motif through which it interacts 
with the PDZ cellular proteins like DLG, MAGI-1 and disrupts the tight junction between 
cells. These interactions contribute to the oncogenecity of adenovirus since the disruption 
of tight junctions and loss of apicobasal polarity are common features of the epithelial 
cancer cells (Latorre et al., 2005). In addition, domain 2 motif (consisting of seven amino 
acids) of E4 ORF1, which binds to a cellular phosphoprotein, phosphatidylinositol 3-
kinase (PI3K) and activates PI3K (Chung et al., 2007). The PI3K plays an important role 
in signaling pathway regulating cellular metabolism, survival and proliferation, and has 
been shown to be commonly activated in many types of cancer (Mills et al., 2001).  
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The E4 ORF3 binds to E1B-55kDa protein and induces the reorganization of 
nuclear bodies called as ND10 domains or PML oncogenic domains (PODs) (Hoppe et 
al., 2006). The ND10 domains are granular nuclear bodies present in the nucleus and 
contribute many cellular functions like transformation, DNA repair and apoptosis. The 
disruption of ND10 domains favors the adenoviral DNA replication (Weitzman, 2005). 
The PML proteins belong to tripartite motif (TRIM) family of proteins, which contain a 
RBCC domain (Nisole et al., 2005). The RBCC domain present in transcriptional 
regulator TIF1  (TRIM protein) is considered to mediate the protein-protein interactions 
between the E4 ORF3 and TIF1  (Yondola and Hearing, 2007). The functional 
significance of this interaction is not known.  In addition, E4 ORF3 interacts with double-
strand break repair (DSBR) protein kinase (DNA-PK) resulting in regulating the 
subnuclear localization of CBP (transcriptional regulator) and preventing the concatemer 
formation resulting in viral DNA replication (Araujo et al., 2005; Hart et al., 2006). 
The interaction of E4 ORF4 with Src kinases triggers the p53 independent cell 
killing, which subsequently deregulates the Src signaling complex (Lavoie et al., 2000; 
Champagne et al., 2004). Hence, it plays a role in the induction of the cytoplasmic death 
pathway.  
The E4 ORF6 shows oncogenic potential in cooperation with E1B-55K and 
blocks p53 mediated transcriptional activity (Dobner et al., 1996; Goodrum and Ornelles, 
1999; Orlando and Ornelles, 2002). During the adenovirus infection, the E4 ORF6 
interacts with E1B-55K and other cellular proteins (e.g. elongins B, cullin5) to form an 
E3 ubiquitin ligase complex that polyubiquitinates MRE11-RAD50-NBS1 (MRN) 
complex, resulting in its degradation by proteosomes. (Liu et al., 2005). The MRN 
complex enables exonucleolytic and endonucleolytic activities, which help in 
nonhomologous end joining.  
 
1.1.4.2 Interactions during intermediate gene expression 
   During the intermediate gene expression, pIX and IVa2 genes are expressed. 
The HAdV-5 pIX protein interacts with group of nine (GON) hexons, confering the 
stability to viral capsid (Vellinga et al., 2005). The pIX deleted HAdV-5 virions are heat 
labile and fail to produce GON structures upon capsid dissociation (Vellinga et al., 2005). 
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In addition, the pIX interact with ND10 domains and disrupt the ND10 domains 
providing an environment favorable for the replication of HAdV-5 (Rosa-Calatrava et al., 
2003). The C-terminus leucine repeats of pIX are responsible for the interaction of pIX 
with other proteins (Rosa-Calatrava et al., 2001). 
The HAdV-5 IVa2 protein interacts with 52/55K protein and AT rich region in 
viral DNA packaging sequences, suggesting a role in viral assembly (Zhang and 
Imperiale, 2003) and DNA packaging (Zhang et al., 2001; Ostapchuk et al., 2005). These 
interactions are essential in viral assembly since the lack of either protein result in the 
absence of progeny virus formation (Perez-Romero et al., 2006). It also interacts with VII 
and 52/55K proteins, which is thought to be important for viral DNA packaging (Zhang 
and Arcos, 2005). Recently, it has been shown to interact with ATP and subsequently 
hydrolyze ATP (Ostapchuck and Hearing, 2008), which may be required for the viral 
DNA packaging during adenovirus assembly. The interaction of IVa2 protein with 
52/55K protein has also been shown to regulate the transcriptional activation of the major 
late promoter (Gustin et al., 1996; Perez-Romero et al., 2006; Tribouley et al., 1997; 
Pardo-Mateos and Young, 2004).  
 
1.1.4.3 Interactions during late gene expression 
   During the late phase of adenovirus life cycle, there is reduction in the early 
gene expression followed by viral assembly. The adenovirus assembly requires 
scaffolding proteins assisted assembly pathways, which are dependant on protein 
localization as well as protein-protein interactions. The scaffolding proteins mediate 
proper assembly of precursor capsids (procapsids) during assembly. After assembly, 
scaffolding proteins are removed followed by viral DNA packaging (D'Halluin et al., 
1978). 
The HAdV-5 L1 protein 52K/55K plays an important role in the late phase of 
adenovirus life cycle. The 52/55-kDa (N-terminal 173 amino acids) protein interacts with 
IVa2 protein specifically during the adenovirus infection, thereby regulating transcription 
from the major late promoter (Gustin et al., 1996; Perez-Romero et al., 2006). The 
interaction of N-terminal 331 amino acids of 52/55-kDa protein with IVa2 protein helps 
to bind to packaging sequences in vivo (Perez-Romero et al., 2005, 2006). Its interaction 
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with VII and IVa2 plays an important role in packaging of viral DNA (Zhang and Arcos, 
2005). 
The HAdV-5 L2 protein VII strongly interacts with cellular nuclear import 
receptors like importin alpha, importin beta and transportin, resulting in the entry of 
protein VII to the nucleus of the cells (Wodrich et al., 2006). In addition, it also interacts 
with histone chaperone like template activating factor (TAF), which helps in remodeling 
of the adenovirus chromatin and stimulates the transcription and replication of adenovirus 
in vitro (Gyurcsik et al., 2006). It also interacts with IVa2 and L1 52K/55K protein and 
plays a role in packaging of viral DNA (Zhang and Arcos, 2005). 
  The HAdV-5 L3 pVI protein interacts with hexon and is responsible for the 
transport of hexon capsomeres to the nucleus (Matthews and Russell, 1995). In addition, 
the C-terminus of pVI interacts with adenoviral protease (AdVP) for maximizing 
enzymatic activity of AdVP (Bajpayee et al., 2005).                        
The HAdV-5 L4 encodes 100K and 33/22K proteins. The 100K protein plays an 
important role in various aspects of the adenovirus life cycle.  It binds the hexon protein 
via its globular domain, transports newly synthesized hexon monomers from the 
cytoplasm to the nucleus and helps in the trimerization of hexon monomers (Hodges et 
al., 2001; Hong et al., 2005).  It has the selective binding element for the tripartite leader 
which forms a complex with initiation factor eIF4G and poly (A)-binding protein 
(PABP).  
The HAdV-5 33K protein, forms a complex with IVa2 protein and stimulates late 
phase transcription by binding to the major late promoter (Ali et al., 2007). The 22K form 
of  the protein along with IVa2 protein bind the adenovirus packaging domain suggesting 
a role of 22K protein in adenoviral DNA encapsidation (Ostapchuk et al., 2006).  
 
1.2 Bovine adenovirus 
Bovine adenovirus (BAdV) has been isolated from cattle, African buffalo, sheep 
and deer (Darbyshire, 1965). There are ten reported serotypes of bovine adenovirus 
(Reddy et al., 1998). Depending upon different characteristics including genome 
organization and A+T rich content of genome, these serotypes are  classified in two 
genera Mastadenovirus (BAdV-1, BAdV-3, BAdV-10, BAdV-9 and BAdV-2) and 
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Atadenovirus (BAdV-4, BAdV-5, BAdV-8, BAdV-6 and BAdV-7 ; Davison et al., 2003).  
Different serotypes belonging to Mastadenovirus genus is further classified into five 
species (Davison et al., 2003) namely BAdV A (BAdV-1), BAdV B (BAdV-3), BAdV C 
(BAdV-10), HAdV C (BAdV-9) and OAdV A (BAdV-2).  Similarly serotypes belonging 
to Atadenovirus genus are further classified into three species (Davison et al., 2003) 
namely BAdV D (BAdV-4,-5,-8), BAdV E (BAdV-6) and BAdV F (BAdV7).  BAdV 
type -1, -2, -3, and -9 grow relatively well in established bovine cell lines and induce a 
single nuclear inclusion of irregular shape. BAdV type 4, 5, 6, 7, 8, and 10) can be 
propagated in low-passage cultures of calf testicular or thyroid cells and usually form 
multiple inclusions of circular shape with sharp outlines (Bartha, 1969).The calves 
infected with BAdV-1, BAdV-2 or BAdV-3 show no clinical symptoms while calves 
infected BAdV-4 and BAdV-5 have been shown to cause bronchopneumonia  (Mohanty, 
1971). BAdV-7 was first isolated from a cow having a febrile illness (Inaba et al., 1968). 
Previous study has shown that bovine adenoviruses can induce tumors in rodents and 
transform non-permissive cells in tissue culture (Darbyshire et al., 1966). Of these, 
BAdV-3 is best characterized and has been shown to be the best candidate as a vaccine 
vector (Baxi et al., 2001; Reddy et al., 1999; Zakhartchouk et al., 1999; 2004) because of 
its low virulence and the ability of the virus to grow to high titers in cell culture 
(Lehmkuhl et al., 1975).  
BAdV-3 was first isolated from the conjunctiva of an apparently healthy cow in 
Great Britain (Darbyshire et al., 1965). BAdV-3 is a non-enveloped icosahedral particle 
with a diameter of 75-nm and contains a double stranded DNA genome of 34,446 base 
pairs (Reddy et al., 1999) flanked by 195 bp inverted terminal repeats (Shinagawa et al., 
1987). The cis-acting packaging sequences are localized within 224-250 nucleotides on 
the left end of the BAdV-3 genome (Xing et al., 2003). The transcription map of BAdV-3 
is shown in Fig. 1.1. Like HAdVs, the BAdV-3 genome is also organized into early, 
intermediate and late regions. The early region (E) comprises four transcriptional units- 
E1, E2, E3 and E4. However, the late region is organized into seven regions L1-L7 
(Reddy et al., 1998).  
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1.2.1 Early gene expression 
   Molecular characterization of the early region of BAdV-3 has been reported (Reddy et 
al., 1998). As in HAdV, the E1 transcriptional unit of BAdV-3 is located at the left end of 
the genome and has ORFs coding for the proteins homologous to the E1A and E1B 
region of HAdV-5 (Reddy et al., 1998). The conserved regions of E1A promoter of 
BAdV-3 are located within the ITRs (Xing and Tikoo, 2006).The mRNAs of E1A and 
E1B share same poly A signal suggesting that the E1A and E1B transcripts of BAdV-3 
are 3` co-terminal. (Reddy et al., 1999). Within the E1A region of BAdV-3, several 
mRNAs are produced as a result of alternative splicing, which encodes 211R, 115R and 
100R proteins (Reddy et al., 1999a). The E1A protein sequences do not show the 
consensus nuclear localization signal (NLS). It appears that E1A interaction with cellular 
proteins that help E1A proteins localize to the nucleus (Reddy et al., 1999a). The E1A 
region proteins of BAdV-3 are essential for virus replication and transactivation of early 
viral genes (Zhou et al., 2001).  
The E1B region of BAdV-3 encodes two major overlapping mRNAs (Reddy et 
al., 1999). The E1Bsmall mRNA encodes the 157R protein, which is the homolog of the 
HAdV-5 19K protein (Zheng et al., 1994). Interestiongly, E1Bsmall appears essential for 
BAdV-3 replication in fibroblast cells (Zhou et al., 2001). The E1Blarge mRNA is 
translated into a 420R protein, which is a homologue of HAdV-5 55K protein. Mutational 
analysis of the E1B region has shown that E1Blarge is essential for BAdV-3 replication 
(Zakhartchouk et al., 2001; Zhou et al., 2001).  
The E2 region of BAdV-3 is transcribed leftward on the “l” strand producing 
several mRNAs by differential splicing of the primary transcript. The E2 region encodes 
the DNA replication proteins and is further divided into the E2A region and E2B region 
(Reddy et al., 1998).  The DBP encoded by the E2A region of BAdV-3 shows little 
homology with the DBP of other adenoviruses. The DBP of BAdV-3 contains a variable 
N-terminal domain and a conserved C- terminal domain (Reddy et al., 1998). There are 
number of serine and threonine residues at the N-terminus of DBP, which may serve as 
the potential phosphorylation sites (Reddy et al., 1998). DBP is expressed abundantly 
during the early and late phase of BAdV-3 replication (Zhou et al., 2001a). The E2B 
region of BAdV-3 codes for the DNA polymerase (DNA pol) and pre-terminal protein  
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Fig 1.1: Transcription map and genome organization of BAdV-3. The schematic 
diagram showing BAdV-3 genome (34,446 bp; GenBank Acession #AF030154). The 
arrows represent the mRNAs from the “r” and “l” strands, respectively. The solid lines 
represent sequences found in mRNA, broken lines indicate introns, and arrowheads 
represent poly(A) sites and show the direction of transcription. E1 to E4 are early regions. 
(Adapted from Reddy et al., 1998). 
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(pTP). The transcripts of DNA pol and pTP are 3` coterminal (Reddy et al., 1998). 
The E3 region of BAdV-3 is 1.5 kb in length and is transcribed left to right on "r" 
strand of the genome. Four mRNAs transcribed from the E3 promoter are 5’ and 
3’coterminal while one mRNA transcribed from the MLP share the 3’ end (Idamakanti et 
al., 1999). These five transcripts encode four proteins 284R, 121R, 86R and 82R 
(Idamakanti et al., 1999). The protein 284R is a glycoprotein (Idamakanti et al., 1999), 
which shows no homology to proteins encoded by the E3 region of other adenoviruses 
(Reddy et al., 1998).  It is a post translationally modified protein and contains N-terminal 
signal sequence, a hydrophobic transmembrane anchor sequence near C- terminus and 
potential sites for the addition of N-linked oligosaccarides (Idamakanti et al., 1999). The 
121R protein shows little homology to the 14.7K protein encoded by the E3 region of 
HAdV-5 (Reddy et al., 1998) and is not post-translationally modified (Idamakanti et al., 
1999). It inhibits the cytolysis of mouse cells by human tumor necrosis factor 
(Zakhartchouk et al., 2001). The isolation of replication competent E3-deleted BAdV-3 
suggests that the E3 region of BAdV-3 is non-essential for virus replication in vitro 
(Zakhartchouk et al., 1998) or in vivo (Zakhartchouk et al., 1999). Hence, the foreign 
genes under the control of promoters like mouse cytomegalovirus (MCMV) immediate 
early promoter are efficiently expressed in E3 region of BAdV-3 with the aim of using 
the BAdV-3 as vectors for the development of vaccines (Zhang et al., 2005). 
The E4 region of BAdV-3 is located on the right side of the BAdV-3 genome and 
is transcribed right to left from the "l" strand of the genome. The BAdV-3 E4 region is 3 
kb in length. This region is transcriptionally active at early and late times post infection. 
The E4 region of BAdV-3 produces seven transcripts, which can encode at least five 
unique proteins namely 143R (ORF1), 69R (ORF2), 286R (ORF3), 143R2 (ORF4) and 
219R (ORF5) (Baxi et al., 1999). The proteins encoded by the E4 ORF3 and E4 ORF5 of 
BAdV-3 show partial homology to the 34 kDa protein of HAdV-2 (Baxi et al., 1999). 
BAdV-3 E4 deletion studies have shown that none of the individual ORFs (ORF1 to 
ORF5) appear to be essential for the viral replication (Baxi et al., 2001) 
 
1.2.2 Intermediate gene expression 
Two genes, pIX and IVa2 comprise the intermediate region. The pIX protein of 
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BAdV-3 is a 14 kDa protein comprising 125 amino acids and is a component of BAdV-3 
capsid (Reddy et al., 1999a). The BAdV-3 protein pIX shows less than 30% homology 
with pIX proteins of other HAdVs. The BAdV-3 pIX transcript is 3' coterminal with 
those of E1A and E1B. The C-terminus of pIX is exposed on the surface of BAdV-3 and 
hence is exploited as a site for the incorporation of targeting ligands (small or longer 
polypeptides) with the aim of developing BAdV-3 as vector for gene therapy 
(Zakhartchouk et al., 2004).  Another intermediate protein, IVa2 protein of BAdV-3 is 
376 amino acids in length, which is shorter than IVa2 proteins of other adenoviruses. 
 
1.2.3 Late gene expression 
Like in HAdVs (Chow et al., 1977), the mRNAs transcribed from the MLP of 
BAdV-3 contain a 5' non-coding segment which is known as the tripartite leader (TPL) 
(Reddy et al., 1998) which is 205 nucleotides in length. The first leader of the TPL is 40 
nucleotides in length and is adjacent to the MLP. The second leader is 78 nucleotides in 
length and is located within the gene encoding DNA polymerase. The third leader is 87 
nucleotides in length and is located within gene encoding pTP (Reddy et al., 1998). The 
late region of BAdV-3 produces several mRNAs, which are grouped into seven families 
of mRNAs (L1 to L7) (Reddy et al., 1998).  
The L1 region codes four genes- namely 52k, pIIIa, pIII and pVIII, whose 
mRNAs have a common poly A signal. The 52k protein is 331 amino acids in length and 
is smaller than 52K of other HAdVs due to a large C- terminal deletion (Reddy et al., 
1998). The pIIIa protein is 568 amino acids long. The BAdV-3 pIII protein is a penton 
base protein comprising of 482 amino acids and contains a MDV motif instead of the 
RGD motif found in HAdV-5 (Reddy et al., 1998). The BAdV-3 pVII protein (171 amino 
acids) is the major coat protein, which has protease cleavage sites at the amino terminus 
of the protein (Reddy et al., 1998). 
The L2 region encodes pV protein, which is 410 residues in length and is rich in 
basic amino acids, especially in the central domain. Like in HAdVs, this protein contains 
a bipartite nuclear localization sequence (NLS) located in the central region of the protein 
(Reddy et al., 1998). 
The L3 region of BAdV-3 encodes the pX protein, which is 80 amino acids in 
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length and is rich in basic amino acids (Reddy et al., 1998). The BAdV-3 pX protein 
contains two protease cleavage sites suggesting that the pX protein of BAdV-3 is cleaved 
by viral proteases. 
The L4 region of BAdV-3 encodes a 282 amino acid pVI protein, which is longer 
than pVI of other HAdVs (Sussenbach and Van der Vliet, 1984). The mature VI protein 
is a minor component of the virion. In BAdV-3, the pVI protein contains two sequence 
motifs near the N- terminus and C- terminus, which are cleaved by endoproteases (Reddy 
et al., 1998). 
The L5 region of BAdV-3 encodes the hexon protein and a proteinase. The 
proteinase of BAdV-3 is 204 amino acids in length and shows homology to proteinase of 
other adenoviruses (Reddy et al., 1998). The hexon protein of BAdV-3 is 910 amino 
acids in length and shows significant homology (45% to 70%) to the hexons of other 
adenoviruses (Reddy et al., 1998). The hexon proteins of different adenoviruses can be 
differentiated by differences in the external loops L1 and L2 (Athappilly et al., 1994). In 
BAdV-3, the L1 loop is shorter than that of HAdVs due to the absence of the region rich 
in acidic amino acids, which is normally present in HAdVs (Athappilly et al., 1994). 
Unlike in other adenoviruses, there is no overlapping of ORFs of BAdV-3 hexon and 
endoprotease (Reddy et al., 1998).   
The L6 region of BAdV-3 encodes two non-structural proteins namely 100K and 
33K, and one structural protein pVIII. The 100K protein is 850 amino acids in length and 
is longer than that of the 100K protein of other HAdVs. The 33K protein of BAdV-3 is 
predicted to code for a protein of 274 amino acids in length in the absence of splicing and 
279 amino acids in length in the presence of splicing (Reddy et al., 1998). In BAdV-3, 
the 100K ORF slightly overlaps the 33K ORF. The 33K protein of BAdV-3 is expressed 
as 42, 38, and 33 kDa isoforms in BAdV-3 infected cells (Kulshreshtha et al., 2004).  The 
33K protein has also been shown to be involved in capsid assembly and efficient DNA 
capsid interaction (Kulshreshtha et al., 2004). The BAdV-3 pVIII protein is 216 amino 
acid residues long and contains two protease cleavage sites (Reddy et al., 1998). 
The L7 region of BAdV-3 encodes fiber protein. Like in HAdV-5, the fiber of 
BAdV-3 is comprised of a shaft, head and the tail region. The tail and head region of 
BAdV-3 is almost similar in size to that of HAdVs. However, the shaft of BAdV-3 fiber 
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protein is comparatively larger (976 amino acids) than that of HAdVs due to the presence 
of 46.5 repeats of 15-residue repeats (Ruigrok et al., 1994). The fiber of BAdV-3 appears 
to be bent at one or more places, which have not been obeserved in any other 
adenoviruses (Ruigrok et al., 1994). An amino terminus hydrophobic sequence motif 
[FNPVYPY (D/E)] of HAdV-5 fiber, involved in the specific interaction between the 
fiber and penton base proteins (Caillet-Boudin, 1989) is strongly conserved in BAdV-3 
fiber (Reddy et al., 1998). Like HAdV-5 (Chroboczek et al., 1995), the carboxy-terminal 
domain or head of the BAdV-3 fiber protein begins at the well-conserved TLWT motif 
(Reddy et al., 1998). The fiber of BAdV-3 is expressed as 102 kDa glycoprotein and is 
localized to the nucleus of the infected cells (Wu et al., 2004).       
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2.0 OBJECTIVES 
Although advances in recombinant DNA technology have led to the identification 
of potent vaccine antigens, one of the impediments in the development of effective 
vaccines has been the appropriate delivery of vaccine. Currently, a number of viruses are 
being evaluated as vaccine delivery vehicles (Robert-Guroff, 2007). The development of 
efficient live viral vector systems requires a comprehensive knowledge of the interplay 
between virus and host cell.   
Since BAdV-3 is non pathogenic and grows to high titers, our laboratory has been 
carrying out molecular characterization of bovine adenovirus (BAdV) -3 (Tikoo, 2001) 
with the aim of developing BAdV-3 as an efficient vector for gene delivery in humans 
and animals. Although our laboratory has developed the first generation of E3 deleted 
BAdV-3 vectors (Zakhartchouk et al., 1998), they replicate and excreate progeny virus 
thus transmitting virus to other farm animals. Moreover, large dose of vector is needed to 
produce protective immune responses.   
Since the assembly of mature adenovirus is a multi-step process involving 
protein-protein (homotypic / heterotypic) and protein-DNA interactions, the involvement 
of the non structural proteins in various steps of adenovirus virus replication and 
assembly may require the direct protein-protein interactions. By determining the 
structure, function and importance of interaction of other viral and cellular proteins with 
non structural proteins, we may be able to develop BAdV-3 vectors (expressing vaccine 
antigens inserted in E3 region), which can replicate the recombinant BAdV-3 genome 
and thus amplify transgene expression without the production of infectious virus. 
Moreover, detailed knowledge of these protein-interactions is critical for understanding 
the biology of virus. 
Most adenoviruses contain a collinear homolog of a non structural protein 
designated 33K. Since the 33K protein appears to be involved in viral assembly, we 
hypothesize that 33K protein may interact with other viral and/or cellular proteins during 
assembly. The present study is directed towards the molecular characterization and 
interactions of 33K protein of BAdV-3.  
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The primary objective is achieved with the following aims: 
 
1. Characterization of 33K protein of BAdV-3. 
2. Interaction of BAdV-3 33K protein with other viral proteins. 
3. Interaction of BAdV-3 33K protein with cellular proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 31
3.0 CHARACTERIZATION OF 33K PROTEIN OF BAdV-3 
 
 3.1 Introduction 
Adenoviruses contain a non-enveloped, double-stranded DNA genome of 26kb to 
45kb with a G+C content of 33-63% (Davison et al., 2000). The adenovirus genome is 
organized into complex transcriptional units comprising of early, intermediate and late 
regions. Expression of the early and intermediate transcription units precedes the onset of 
viral DNA replication. However, expression of the late transcription units is dependent on 
the initiation of viral DNA replication and expression of the major late transcription unit 
(MLTU), which is controlled by the major late promoter (MLP) (Thomas and Mathews, 
1980). The late transcriptional units encode structural and nonstructural proteins involved 
in the formation of progeny virions.  
Bovine adenovirus (BAdV) - 3 is a member of subgroup I of BAdVs and is being 
developed as a potential vector for animal vaccines (Baxi et al., 2001 and Zakhartchouk 
et al., 1999; 2004) and human gene delivery (Rasmussen et al., 1999). Complete DNA 
sequence of the BAdV-3 genome has already been reported (Reddy et al., 1998). Like 
human adenovirus (HAdV) -5, the BAdV-3 genome is organized into early, intermediate, 
and late regions (Reddy et al., 1998). Unlike HAdV-5, the late region of BAdV-3 genome 
is organized into seven regions, L1–L7 (Reddy et al., 1998). The L6 region of the late 
transcription unit of BAdV-3 encodes 33K and 22K protein (Reddy et al., 1998; 
Kulshreshtha et al, 2004). Earlier, using anti-33K serum we detected three proteins of 42 
kDa, 38kDa and 33kDa (Kulshrestha et al., 2004). The L6 33K protein is a product of a 
spliced transcript, while 22K protein is translated from the unspliced form of this 
transcript (Reddy et al, 1998).  The 33K and 22K proteins share a N-terminus region of 
138 amino acids.  
Recently, adenovirus 33K protein has been shown to act as an alternative RNA 
splicing factor (Tormanen et al., 2006), a transcriptional activator (Ali et al., 2007) and to 
induce early to late switch of major late transcription unit expression (Farley et al., 2004). 
Moreover, adenovirus 22K has been shown to be involved in the packaging of adenovirus 
genome (Ewing et al., 2007; Ostapchuk et al., 2006). Here, we report the structure and 
functions of BAdV-3 33K protein. 
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3.2. Materials and methods 
3.2.1. Cell lines and virus  
Madin-Darby bovine kidney (MDBK) cells and 293T cells were cultured in 
minimal essential medium (MEM) (Gibco-BRL) containing 10% fetal bovine serum 
(FBS). HeLa cells were cultured in Dulbecco's modified MEM containing 10% FBS. The 
wild-type BAdV-3 was cultivated in MDBK cells as described (Reddy et. al, 1999). 
 
3.2.2. RT-PCR analysis 
RNA was extracted from BAdV-3 infected MDBK cells at 48h post infection 
using RNeasy kit (Qiagen). The first strand cDNA was synthesized using superscript II 
reverse transcriptase and oligo (dT) primers (Invitrogen). The cDNA was amplified by 
performing PCR using the L6 region specific primers (5’- GGAATTCTG A 
TGAAACCCCGCAGCATGTC-3’ and 5’-GTAATCTTGACTGGCACCTG-3’). The 
PCR product(s) was ligated to SmaI digested pGEX-5X-1 (Pharmacia). The plasmid 
DNA was used to determine the DNA sequence of PCR product (s).  The plasmids 
containing unspliced 22K and spliced 33K were designated as pGEX.22K and 
pGEX.33K respectively. 
 
3.2.3 Plasmid construction  
       a) Construction of   pEY.33K, pEY.33Kg2, pEY.33Kg3 
 i) A 845 bp fragment containing 33K ORF (Spliced) was amplified by PCR 
[using primers P1 and P4 (Table 3.1), and plasmid pGEX.33K DNA as a template], 
digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested plasmid pEYFP-N1 
(Clontech) creating plasmid pEY.33K.  
ii) A 825bp fragment containing 33K ORF (spliced) initiating from 2nd ATG was 
amplified by PCR [using primers P2 and P4 (Table 3.1), and plasmid pGEX.33Ks DNA 
as template], digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested pEYFP-
N1 creating plasmid pEY.33Kg2. 
iii) A 525bp fragment containing 33K ORF (spliced) initiating from 3rd ATG was 
amplified by PCR [using primers P3 and P4 (Table 3.1) and plasmid pGEX.33Ks DNA 
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as template], digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested pEYFP-
N1 creating plasmid pEY.33Kg3.  
b) Construction of  pC.33K, pC.33Kg2 and pC.33Kg3 
 i) A 845 bp NdeI-EcoRI fragment of plasmid pGEX.33K  was isolated, blunt end 
repaired with T4 polymerase and ligated to  HindIII digested (blunt end repaired 
with T4 polymerase)  pCDNA3 (Invitrogen), creating the plasmid pC.33K.  
ii) A 862 bp NdeI-AscI fragment of plasmid pEY.33Kg2 was isolated and ligated to 
5.4 kb NdeI-AscI digested plasmid pC.33K creating plasmid pC.33Kg2.  
iii) A 649 bp AatII-EcoRI fragment of plasmid pC.33K was isolated, blunt end 
repaired with T4 polymerase and ligated to HindIII digested (blunt end repaired with T4 
polymerase) plasmid pcDNA3, creating  plasmid pC.33Kg3. 
 c) Construction of pC.22K, pC.22Kss, pC.22KS1, pC.22KssS2  
i) pC.22K.  A 835 bp fragment was amplified by PCR using primers P20 and P37 and 
plasmid DNA pSM12 (Kulshrestha et al., 2004) DNA as a template. The PCR fragment 
was digested with SacII-EcoRI and ligated to 5.4 kb SacII-EcoRI fragment of plasmid 
pC.33K creating plasmid pC.22K. 
ii) pC.22Kss. A 425 bp fragment was amplified by PCR using the primers P20 and 
P35 and plasmid pC.22K DNA as a template. Similarly, a 600 bp fragment was amplified 
from by PCR using the primers P22 and P36 (Table 3.1), and plasmid pC.22K DNA as a 
template. In a third PCR reaction, both amplified fragments were annealed and external 
primers P20 and P37 (Table 3.1), were used to PCR across to give a 840 bp amplicon. 
This PCR product was digested with SacII-EcoRI and ligated to SacII-EcoRI digested 
pC.33K creating plasmid pC22Ks (splice donor site GT removed to GC). 
A 580 bp fragment was amplified from by PCR using the primers P20 and P38 (Table 
3.1), and plasmid pC.22Ks DNA as a template. Similarly, a 427 bp fragment was 
amplified from by PCR using the primers P22 and P39 (Table 3.1), and plasmid pC.22Ks 
as a template. In a third PCR reaction, both amplified fragments were annealed and 
external primers P20 and P37 (Table 3.1) were used to PCR across to give a 840 bp 
amplicon. This PCR product was digested with SacII-EcoRI and ligated to SacII-EcoRI 
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Table 3.1 Sequence of primers for the construction of 33K deletion plasmids  
Primer     Sequence       
P1 5’-GGAATTCTGATGAAACCCCGCAGCATGTC-3’   
P2 5’-GGAATTCTGATGTCGGCAGCCGGGCCT-3’ 
P3  5’-GGAATTCTGATGATTTCGATACCCCGCGA-3’ 
P4 5’-CGGGATCCCGGGCGGGTCCGGATTCGTC-3’ 
P5  5’-GGATTTCCAAGTCTCCAC-3’   
P6 5’-CATCATATGCAGGTCCTCCTC-3’ 
P7 5’-GCTTCTCTGAATCCCACCGC-3’ 
P8 5’-GGAATTCTGAATGGCTTCTCTGAATCCCAC-3’ 
P9 5’-AGGGCGAGGCTTGCCCTGGCCCTTCTTG-3’ 
P10 5’-CAGGGCAAGCCTCGCCCTCCTCCTCTT-3’ 
P11 5’-GAGAGTGGGCGCGCTGGCACTCCGC-3’ 
P12  5’-GCCAGCGCGCCCACTCTCTATGCCATAT-3’ 
P13 5’-GTCCTCGATGTTGTGGCGG-3’ 
P14 5’-GGTTCGCTGAAAGATCAGCTCCCGAAGCTT-3’ 
P15 5’-CTGATCTTTCAGCGAACCCTAGCAGACT-3’ 
P16 5’-GGCGGGTCCGAGCTGTTCCTCCCTTGTTGT-3’ 
P17 5’-GAACAGCTCGGACCCGCCTAAGAATTCC-3’ 
P18 5’-GGTTCGCTGGCGCGTCA G TGAACGTA AG-3’ 
P19 5’-CTGACGCGCCAGCGAACCCTA GCAGAC T-3’ 
P20 5’-GGAATTCCATATGATGAAACCCCGCAGCATGTCG-3’ 
P21 5’-CCGCTGAGCGATCA GCTCCCGAAGCTTG-3’ 
P22 5’-GAAGGCACAGTCGAGGCT-3’ 
P23 5’-GAGCTGATCGCTCAGCGGTGTCACCTC-3’ 
P24 5’-GGAATTCCTTAGGCGGGTCCGGATTCG-3’ 
P25 5’-GTGGTAGAGGAGAG TGGGAAAGATCAGCT-3’ 
P26 5’-CCCACTCTCCTCTACCACAACAAGGAGGAA-3’ 
P27 5’-TTTCACTTTGGCG TGACACCGC-3’ 
P28 5’-CGGTGTCACGCCAAAGTGAAAAAT-3’ 
P29 5’-CAGTGAACGTGCGGATCTATTTTTC-3’ 
P30 5’-AATA GATCCGCACGTTCACTGACG-3’ 
P31 5’-GTTGTGGTAGGC GCAGCTGCG-3’ 
P32 5’-CGCAGCTGCGCCTACCACAAC-3’ 
P33 5’-GGTTCGCTGGGCCT GTTCCTC-3’ 
P34 5’-GAGGAACAGGCCCAGCGAACC-3’ 
P35 5’-GCTCCTCTTGCCTCTAGCGCC-3’ 
P36 5’-GCTAGAGGCAAGAGGAGCTAC-3’ 
P37 5’-GGAATTCCTATTTTTCACTTTGAGGTG-3’ 
P38 5’-TTCGGGTCGGCAGTAAGAATT-3’ 
P39 5’-TCTTACTGCCGACCCGAAGC-3’ 
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digested pC.22K creating plasmid pC.22Kss (splice donor and splice acceptor site 
removed).  
iii) pC.22KS1. A 835 bp NdeI-EcoRI fragment amplified by PCR using primers P20 
and P37 (Table 3.1), and plasmid pSM12 (Kulshrestha et al., 2004) DNA as a template 
and ligated to 7.2kb NdeI-EcoRI digested plasmid pGBKT7 (Clontech) creating plasmid 
pGBK-22. A 8.1 kb NcoI fragment (blunt end repaired by T4 polymerase) of 
pGBKT7.22K was ligated to a XbaI linker (containing three way stop codon) creating the 
plasmid pGBKT7.22Ks. A 310 bp PshAI-AscI fragment of plasmid pGBKT7.22Ks and 
ligated to 5.9 kb PshAI-AscI fragment of pC.22K creating the plasmid pC.22KS1. 
iv) pC.22KssS2. A 425 bp fragment was amplified by PCR using the primers P20 and 
P35 (Table 3.1), and plasmid pC.22KS1 as a template. Similarly, a 600 bp fragment was 
amplified from by PCR using the primers P22 and P36 (Table 3.1),and plasmid 
pC.22KS1 DNA as a template. In a third PCR reaction, both amplified fragments were 
annealed and external primers P20 and 37 (Table 3.1), were used to PCR across to give a 
840 bp amplicon. This PCR product was digested with SacII-EcoRI and ligated to SacII-
EcoRI digested pC.33K creating plasmid pC22Ks (splice donor site GT removed to GC) 
A 580 bp fragment was amplified from by PCR using the primers P20 and P38 (Table 
3.1), and plasmid pC.22KS1 as a template. Similarly, a 427 bp fragment was amplified 
from by PCR using the primers P22 and P39 (Table 3.1), and plasmid pC.22KS1 as a 
template. In a third PCR reaction, both amplified fragments were annealed and external 
primers P20 and P37 (Table 3.1), were used to PCR across to give a 840 bp amplicon. 
This PCR product was digested with SacII-EcoRI and ligated to SacII-EcoRI digested 
pC.22K creating plasmid pC.22KssS2 (splice donor and splice acceptor site removed).  
d) Construction of pEY.33Kd1. A 220 bp fragment was amplified from by PCR using the 
primers P5 and P6 (Table 3.1) and plasmid EY.33K DNA as a template. Similarly, a 725 
bp fragment was amplified by PCR using the primers P4 and P7 (Table 3.1) and plasmid 
pEY.33K DNA as a template. In a third PCR reaction, two PCR fragments that have 9 bp 
of internal overlap were annealed and external primers P4 and P8 (Table 3.1) were used 
to PCR across to give a 765 bp amplicon. This PCR product was digested with EcoRI-
BamHI and ligated to EcoRI-BamHI digested pEYFP-N1 creating plasmid pEY.33Kd1 
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(2-40 amino acid deletion) 
e)  Construction of pEY.33Kd2. A 440 bp SacII-AscI fragment of plasmid p33Kd2 
(Chapter 4.2.3) containing deletion of amino acid 41-80 was isolated and ligated to 5.4 kb 
SacII-AscI fragment of plasmid pEY.33K creating plasmid pEY.33Kd2 (41-80 amino 
acid deletion). 
f)  Construction of pEY.33Kd3. A 440 bp SacII-AscI fragment of plasmid p33Kd3 
(Chapter 4.2.3 ) containing deletion of amino acid 81-120 was isolated and ligated to 5.4 
kb SacII-AscI fragment of plasmid pEY.33K creating plasmid pEY.33Kd3 (81-120 amino 
acid deletion). 
g) Construction of pEY.33Kd4. A 360 bp fragment was amplified from by PCR using the 
primers P1 and P9 (Table 3.1), and plasmid EY.33K DNA as a template. Similarly, a 375 
bp fragment was amplified by PCR using the primers P4and P10 (Table 3.1), and plasmid 
pEY.33K DNA as a template. In a third PCR reaction, two PCR fragments that have 9 bp 
of internal overlap were annealed and external primers P1 and P4 (Table 3.1) were used 
to PCR across to give a 765 bp amplicon. This PCR product was digested with EcoRI-
BamHI and ligated to EcoRI-BamHI digested plasmid pEYFP-N1 creating plasmid 
pEY.33Kd4 (121-160 amino acid deletion).  
h) Construction of pEY.33Kd5. A 485 bp fragment was amplified by PCR using the 
primers P1 and P11 (Table 3.1), and plasmid pEY.33K DNA as a template. Similarly, a 
905 bp fragment was amplified by PCR using the primers P12 and P13 (Table 3.1), and 
plasmid pEY.33K DNA as a template. In a third PCR reaction, two PCR fragments that 
have 9 bp of internal overlap were annealed and external primers P1 and P4 (Table 3.1) 
were used to PCR across to give a 765 bp amplicon. This PCR product was digested with 
EcoRI-BamHI and ligated to EcoRI-BamHI digested plasmid pEYFP-N1 creating 
plasmid pEY.33Kd5 (161-200 amino acid deletion). 
i) Construction of pEY.33Kd6. A 610 bp fragment was amplified by PCR using the 
primers P1 and P14 (Table 3.1), and plasmid EY.33K DNA as a template. Similarly, a 
660 bp fragment was amplified by PCR using the primers P15 and P13 (Table 3.1), and 
plasmid pEY.33K DNA as a template. In a third PCR reaction, two PCR fragments that 
have 9 bp of internal overlap were annealed and external primers P1 and P4 (Table 3.1) 
were used to PCR across to give a 765 bp amplicon. This PCR product was digested with 
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EcoRI-BamHI and ligated to EcoRI-BamHI digested plasmid pEYFP-N1 creating 
plasmid pEY.33Kd6 (201-240 amino acid deletion). 
j) Construction of pEY.33Kd7. A 730 bp fragment was amplified by PCR using the 
primers P1 and P16 (Table 3.1), and plasmid EY.33K DNA as a template. Similarly, a 
525 bp fragment was amplified from by PCR using the primers P17 and P13 (Table 3.1), 
and plasmid EY.33K DNA as a template. In a third PCR reaction, two PCR fragments 
that have 9 bp of internal overlap were annealed and external primers P1 and P18 (Table 
3.1) were used to PCR across to give a 765 bp amplicon. This PCR product was digested 
with EcoRI-BamHI and ligated to EcoRI-BamHI digested plasmid pEYFP-N1 creating 
plasmid pEY.33Kd7 (241-275 amino acid deletion). 
k) Construction of pEY.33Kd6a, pEY.33Kd6b, pEY.33Kd6c 
 i) A 597 bp SacII-BlpI fragment of plasmid pC.33Kd6a to 4.9 kb SacII-BlpI fragment 
of pEY.33K plasmid creating plasmid pEY.33Kd6a (200-211 amino acid deletion). 
 ii) A 764 bp fragment was amplified from by PCR using the primers P1 and P4 
(Table 3.1), and plasmid pC.33Kd6b DNA as a template. This PCR product was digested 
with EcoRI-BamHI and ligated to EcoRI-BamHI digested EYFP-N1 plasmid creating the 
plasmid pEY.33Kd6b (204-231 amino acid deletion) 
iii) A 686 bp fragment was amplified from by PCR using the primers P1 and P18 
(Table 3.1), and plasmid pEY.33K DNA as a template. Similarly, a 660 bp fragment was 
amplified from by PCR using the primers P13 and P19 (Table 3.1), and plasmid 
pEY.33K DNA as a template. In a third PCR reaction, both amplified fragments were 
annealed and external primers P1 and P13 (Table 3.1) were used to PCR across to give a 
1.3 kb amplicon. This PCR product was digested with EcoRI-BamHI and ligated to 
EcoRI-BamHI digested EYFP-N1 plasmid creating the plasmid pEY.33Kd6c (230-240 
amino acid deletion). 
l) Construction of pC.33Kd6, pC.33Kd6a, pC.33Kd6b and pC.33Kd6c.  
i) A 683 bp SacII-EcoRI fragment of plasmid pEY.33Kd6 was ligated to 5.4 Kb 
SacII-EcoRI fragment of plasmid pC.33K creating plasmid pC.33Kd6 (201-240 amino 
acid deletion). 
ii) A 600 bp fragment was amplified from by PCR using the primers P20 and P21 
(Table 3.1), and plasmid pC.33K DNA as a template. Similarly, a 373 bp fragment was 
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amplified by PCR using the primers P22 and P23 (Table 3.1), and plasmid pC.33K DNA 
as a template. In a third PCR reaction, both amplified fragments were annealed and 
external primers P20 and P24 (Table 3.1), were used to PCR across to give a 804 bp 
amplicon. This PCR product was digested with SacII-EcoRI and ligated to 5.4 kb SacII-
EcoRI digested pC.33K creating plasmid pC.33Kd6a (200-211 amino acid deletion).  
iii) A 600 bp fragment was amplified from by PCR using the primers P20 and P25 
(Table 3.1), and plasmid pC.33K DNA as a template. Similarly, a 300 bp fragment was 
amplified from by PCR using the primers P22 and P26 (Table 3.1), and plasmid pC.33K 
DNA as a template. In a third PCR reaction, both amplified fragments were annealed and 
external primers P20 and P24 (Table 3.1), were used to PCR across to give a 753 bp 
amplicon. This PCR product was digested with SacII-EcoRI and ligated to SacII-EcoRI 
digested pC.33K creating plasmid pC.33Kd6b (204-231 amino acid deletions). 
iv) A 817 bp fragment was amplified from by PCR using the primers P20 and P24 
(Table 3.1), and plasmid pEY.33K (230-240d) DNA as a template. This PCR product 
was digested with SacII-EcoRI and ligated to 5.4 kb SacII-EcoRI digested pC.33K 
creating plasmid pC33Kd6c (230-240 amino acid deletions). 
 
3.2.4 Production of antisera 
 Production and characterization of antibody recognizing both 33K and 22K have 
been described (Kulshreshtha et al., 2004). To produce protein specific antiserum, two 
peptides (amino acid 141KLTKTATQSKKSRRSASAARPRPPPLPPKRARAPRRPKGQ 
RHQAD185 and 156ASAARPRPPPLPPKRARAPRRPKGQRHQADDASTEGRDKLREL 
IF200) representing 33Ks  and one peptide (amino acid191CRPEADQNRHSEQKEPPECQ 
RGAPSPSSSSSQACSGAPPPQRPAPSGRRRK241) representing 22K were synthesized 
on the Pioneer Peptide Synthesis system (Perkin Elmer) and conjugated to keyhole limpet 
hemocyanin (KLH) as a carrier molecule.  Rabbits were immunized with   conjugated 
peptide (500μg/rabbit) emulsified with Freunds Complete Adjuvant (FCA) followed by 
two injections (conjugated peptide, 250 μg/rabbit) in Freund’s incomplete  adjuvant 
(FIA) at four weeks apart. Serum was collected twelve days after the third injection to 
test for protein specific antibodies. 
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3.2.5 Western blot analysis 
Monolayers of MDBK or 293T cells were infected with wild-type BAdV-3 (MOI 
of 5) or transfected with individual plasmid DNA (2-5μg/106 cells). At indicated times 
post infection, the cells were collected and analyzed by Western blot as described 
(Kulshreshtha et al., 2004) using protein-specific antisera.  
 
3.2.6 Immunofluorescence microscopy 
  The HeLa cells were seeded in four-well Lab-Tek chamber slides. After eighteen 
hours, the cells were transfected with 1μg individual plasmid DNA using lipofectamine 
as per manufacturer’s instructions (Invitrogen). Forty eight hours post-transfection, the 
cells were fixed in 4% paraformaldehyde for 15 minutes, washed four times with PBS 
and permeabilized with ice cold acetone for 5 minutes. The cells were then rinsed with 
PBS and incubated with 4'-6-Diamidino-2-phenylindole (DAPI) for 5 min at room 
temperature. Finally, the cells were washed three times with PBS, mounted in DABCO 
mounting media (Fluka) and analyzed by confocal microscopy. 
 
  3.2.7 Transcriptional Activation Assay 
     Monolayers (80% confluency) of Hela cells in one well of 12 well tissue culture 
plates (Costar) were co-transfected with 0.5 μg per/well of pGL-MLP (luciferase under 
the control of MLP) or pGL-E1A (luciferase under the control of E1A promoter) 
(Zakhartchoukand Tikoo,, unpublished data) with appropriate plasmid. Each transfection 
was performed in triplicate using Lipofectin transfection reagent (Invitrogen) according 
to manufacturer’s directions. 48 hours post-transfection, luciferase expression was 
measured using the Enhanced Luciferase Assay kit (BD Pharmingen™) according to 
manufacturer’s directions. Briefly, following cell lysis, cellular debris was pelleted and 
100 μl of supernatant was taken to luminometer tubes.  100 μl of reaction buffer A was 
added to supernatants and immediately before readings, 100 μl of reaction buffer B was 
added and relative light units were read using the model TD 20/20 luminometer.  Results 
were then tabulated and graphed. 
 
3.3. Results 
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 3.3.1 Determination of 33K and 22K ORFs 
  A recent report suggested that both spliced (33K) and unspliced (22K) forms of 
33K mRNAs are present in HAdV-5 infected cells (Ali et al., 2007). To determine if both 
forms of 33K mRNA is present in BAdV-3 infected cells, we performed RT-PCR 
analysis of mRNA isolated from BAdV-3 infected cells using primers specific for both 
33K spliced and 22K unspliced ORFs (based on Gene bank accession # AC 000002 
sequence). As seen in fig. 3.1A, RT-PCR generated cDNAs of 930 bps using specific 
primers. The cDNA were cloned and sequenced using specific primers.  Analysis of 
DNA sequence identified two types of cDNA clones. The DNA sequence of one type of 
cDNAs was similar to the genomic DNA sequence of predicted 22K. In contrast, DNA 
sequence of second type of cDNAs generated showed an internal splicing of 161 bp 
(Fig.3.1B). Analysis of amino acid sequence of proteins encoded by unspliced (22K) and 
spliced (33K) cDNAs predicted that both proteins have different C-termini but share a N-
terminus 138 amino acids. 
 
3.3.2 Characterization of BAdV-3 33K and 22K proteins 
In order to characterize the 33K and 22K proteins, protein specific antibodies 
were generated by immunizing the rabbits with 500ug of peptides representing unique 
regions of predicted 33K (anti-33Kp serum) protein and 22K (anti-22Kp serum) protein. 
Serum collected after the final boost was analyzed for its specificity by Western blot 
using plasmid DNA (Fig. 3.2A) transfected 293T cells and BAdV-3 infected MDBK cells. 
Anti-33Kp serum detected five major proteins of 42 kDa, 39kDa  37kDa, 21 kDa and 
19kDa, and three minor proteins of  35kDa, 25kDa and 23kDa  in BAdV-3 infected 
MDBK cells at 48 hr post infection (Fig. 3.2B). The 21 kDa band appears to be a doublet. 
Similar protein bands (different intensities) are also detected in 293T cells transfected 
with plasmid expressing 33K protein (Fig. 3.2B). Anti-33Kp serum detected four major 
proteins of 42 kDa  25 kDa, 21kDa and 19kDa  in 293T cells transfected with plasmid 
pC.33Kg2 DNA ( Fig. 3.2B). The 21 kDa band appears to be a doublet.  However, only 
three proteins of 25, 21kDa and 19kDa could be detected in cells transfected with 
plasmid pC.33Kg3 DNA (Fig. 3.2B). Similarly, three proteins of 39kDa, 37 kDa and 21 
kDa could be detected in cells transfected with plasmid pC.33Kd6b DNA (Fig.3.2B) 
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Fig. 3.1.  33K and 22K genes. (A) RT-PCR analysis.   Total RNA isolated from MDBK 
cells at 48 hrs post infection was reverse transcribed using oligo (dT) as a primer. The 
33K/22K specific cDNAs (lane 1) were amplified using primer  5’- GGAATTC TGAT 
GAAA CCCCGCAGCATGTC-3’ and primer 5’-GTAATCTTGACTGGCACC TG-3’. 
Molecular weight marker DNA (M);   (B) Schematic representation of 33K and 22K 
genes. The translation start codon, stop codon and poly A site are depicted. The 
nucleotide numbers represent the genome sequence (GenBank accession # AC  000002). 
The location of the primers is depicted by arrows.   
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Fig. 3.2.  Analysis of BAdV-3 33K and 22K proteins. (A). Schematic representation of 
BAdV-3 33K and 22K.  The coding sequences shared by 33K and 22K (                 ) or 
specific for 33K (               ) and 22K (              ) are depicted. The wild-type (GT…AG) 
and mutated (GC…CG) splice acceptor / donor sites are depicted. The nucleotide 
numbers represent the start and stop codons of the respective genes. The mutated 
nucleotide residues are underlined. The star represents the stop codon. The name of the 
encoded protein is depicted on the right of the panel. 
 
 
     
  1                          415                576                                       1000                    
33K 
22K 
22Kss   
22KssS2 
22KS1 
 1                         415      523     576                    825    
GT        AG 
GT      AG 
GT      AG 
GC      CG 
  1                        415                  576                     825    
GC       CG 
  1                         415      523      576                    825    
  1                          415                 576                    825                      
(A) 
 43
 
 
 
Fig. 3.2 (B). Western blot Analysis. Protein lysates of BAdV-3 infected MDBK cells or 
plasmid DNA transfected 293T cells were separated by 10% SDS-PAGE, transferred to 
nitrocellulose membrane and probed with anti-33Kp serum. The position of the molecular 
weight markers (M) in kDa is shown to the left of the panel. Arrows on the right of each 
panel indicate the position of the identified protein in kDa. 
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Fig. 3.2 (C). Western blot analysis. Protein lysates of  BAdV-3 infected MDBK cells or 
plasmid DNA transfected 293T cells were separated by 10% SDS-PAGE, transferred to 
nitrocellulose membrane and probed with anti-22Kp serum. The position of the molecular 
weight markers (M) in kDa is shown to the left of the panel. Arrows on the right of each 
panel indicate the position of the identified protein in kDa.   
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Surprisingly, anti-33Kp serum detected a major protein of 39 kDa in cells 
transfected with plasmid pC.22K DNA (expressing 22K protein) or plasmid pC.22KS1 
DNA. No such protein could be detected in cells transfected with plasmid pC.22Kss 
DNA or plasmid pC22KssS1 DNA (Fig. 3.2B). 
Anti-22Kp serum detected three major proteins of 41 kDa, 39kDa and 37 kDa in 
BAdV-3 infected cells at 48 hrs post infection (Fig.3.2C).  Anti-22Kp serum detected 
proteins of 39 kDa and 37 kDa in cells transfected with plasmid pC.22Kss DNA (Fig. 
3.2C).  As expected, anti-22Kp serum did not detect any protein in cells transfected with 
plasmid pC.22KssS2 DNA (Fig. 3.2C). No such protein(s) could also be detected in 
mock infected cells (Fig. 3.2C), or cells transfected with plasmid pC.33K DNA (Fig. 
3.2C), plasmid pC.22K DNA (Fig. 3.2C), plasmid pC.22KS1 DNA (Fig. 3.2C) and 
plasmid pCDNA DNA (Fig. 3.2C). 
 
3.3.3 Nuclear localization of 33K 
Earlier, using anti-33K serum (which recognizes both 33K and 22K) we 
demonstrated that 33K / 22K proteins localize to the nucleus of BAdV-3 infected cells 
(Kulshreshtha et al., 2004). To determine if 33K protein is transported to the nucleus of 
the cells, MDBK cells were infected with wild-type BAdV-3 and examined by confocal 
microscopy using anti-33Kp serum. As seen in Fig.3.3, 33K was predominantly localized 
in the nucleus of the infected cells. To determine if 33K protein is transported to the 
nucleus in the absence of other viral proteins, we analysed plasmid pEY.33K DNA 
transfected HeLa cells by con-focal microscopy. Like BAdV-3 infected cells (Fig. 3.3), 
EY.33K was predominantly localized in the nucleus of the transfected cells. Similarly, 
EY.33Kg2 protein initiated at 2nd methionine residue (amino acid 6) or EY.33Kg3 protein 
initiated at third methionine residue (amino acid 87) predominantly localized to the 
nucleus of transfected cells. 
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Fig. 3.3. Indirect immunofluorescence. Monolayers of MDBK cells were infected with 
BAdV-3. After 24 h post infection,  the cells were fixed with 100% methanol and 
analyzed by indirect fluorescence using anti-33Kp serum. Similarly, monolayers of HeLa 
cells were transfected with individual plasmid DNAs expressing 33K proteins initiating 
from different ATGs.  After 48h, the transfected cells were stained with DAPI and 
visualized by confocal microscope. 
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To determine the domain(s) responsible for nuclear localization of 33K protein, a 
panel of plasmids encoding mutant proteins were constructed (Fig. 3.4). These deletions 
were confirmed by restriction enzyme analysis and sequencing of mutant plasmid DNA. 
HeLa cells were transfected with individual mutant plasmid DNAs and analyzed at 48 hrs 
post-transfection by confocal microscopy. As seen in Fig. 3.5, the deletion of amino acids 
2-40 (EY.33Kd1), 41-80 (EY33Kd2), 81-120 (EY.33Kd3) and 120-160 (EY.33Kd4) did 
not affects nuclear localization (Fig. 3.5). Similarly, mutant 33K proteins lacking amino 
acid 161-200 (EY33Kd5) and 241-275 (EY33Kd7) also localized to the nucleus (Fig. 3.5). 
However, compared to 33K, mutant EY.33Kd5 and EY33Kd7 showed granular 
distribution within the nucleus. In contrast, mutant EY.33Kd6 lacking amino acid 201-
240 localized predominantly in the cytoplasm (Fig. 3.5). Taken together these results 
indicate that amino acid 201-240 contain NLS for nuclear localization of BAdV-3 33K 
protein (Fig 3.5).  
To further localize the NLS, we constructed plasmids containing smaller deletions in 
this region of 33K (Fig.3.6A) and analyzed the localization of mutant proteins in 
transfected cells using confocal microscopy. As seen in Fig. 3.6B, none of these deletions 
localized predominantly in cytoplasm. These results suggest that amino acid 201-240 of 
33K may contain multiple NLSs.   
Analysis of the amino acid sequence of BAdV-3 33K protein containing putative 
NLS did not reveal stretches of basic amino acid residues that resemble the classical NLS. 
To determine if amino acids 201-240 contain NLS, we fused this domain to chimeric 
GFP/β-gal protein (Fig. 3.6A; Wu et al., 2004). As expected (Wu et al., 2004), the 
chimeric GFP/β-gal protein was predominantly located in the cytoplasm (Fig. 3.6B). 
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Fig. 3.4.   Schematic representation of BAdV-3 33K-EYFP fusion proteins. The 
number above the box denotes the amino acid number for 33K protein. Thick box 
represent BAdV-3 DNA; hollow box represents EYFP DNA. Dotted lines represent 
deleted regions. The name of the individual mutant protein is given on the right. 
 
 
 
1 279 
41 1 
40      81 
120          161 
160         201 
200         241 
240        276 
EY.33K 
EY.33Kd2 
EY.33Kd1 
EY.33Kd3 
EY.33Kd4 
EY.33Kd5 
EY.33Kd7 
EY.33Kd6 
   80         121 
 49
Fig. 3.5. Subcellular localization of 33K mutant proteins. Monolayers of HeLa cells were 
transfected with individual plasmid DNA expressing 33K-EYFP fusion proteins. At 48hrs post 
transfection, the cells were stained with DAPI and visualized by confocal microscope. 
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Fig. 3.6. Nuclear localization domain of 33K. (A) Schematic representation of BAdV-3 
33K. The coding sequence of 33K (        ), EYFP (          ), GFP (          ) and βgal (          ) 
is depicted. The thin lines represent deleted sequences. The name of the expressed protein 
is shown of the right of the panel.  
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Fig. 3.6. Nuclear localization domain of 33K. (B)  Indirect immunofluorescence. 
Monolayers of HeLa cells were transfected with individual plasmid DNAs.  After 48hrs , 
the transfected cells were stained with DAPI and visualized by confocal microscope. 
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However, the chimeric GFP/β-gal protein fused to 33K NLS domain was 
predominantly localized to the nucleus of the cells (Fig. 3.6B). These results confirm that 
amino acid 201-240 contain essential element(s) of the NLS of BAdV-3 33K protein. 
 
3.3.4 Major Late Promoter Transcription Activation 
To determine if 33K can act as a transactivator, plasmid pMLP.Luc , containing a 
luciferase reporter gene under the control of AdV major late promoter (MLP)  was co- 
transfected into HeLa cells together with  individual plasmid pC.33K or  pC.IVa2 (Fig.  
DNAs (Fig. 3.7A).  As seen in Fig. 3.7B, luciferase expression increased 6-fold when 
pC.33K or pC.IVa2 was co-transfected with the pMLP.Luc.  However, there was no 
increase in luciferase expression when plasmid pC.33K DNA, plasmid pC.IVa2 DNA or 
plasmid pCDNA3 DNA (Fig. 3.7B) was individually co-transfected with the plasmid 
pE1A.Luc DNA (Fig. 3.6B). To determine the domain involved in the activation of MLP, 
selected 33K mutant proteins (Fig. 3.8A) were tested for the transactivation of MLP.  As 
seen in fig.3.8B, deletion of amino acid 161 to 200 of 33K (pC.33Kd5) did not effect the 
transactivation of MLP. However, deletion of a amino acid 201 to 240 of 33K 
(pC.33Kd6) abolished the transactivation of MLP (Fig. 3.7B). To further identify the 
boundaries of the domain, involved in transactivation, we constructed plasmids 
containing smaller deletions between amino acid 201 to 240 of 33K (Fig.3.8A,B) and 
tested them in transactivation assay. As seen in fig. 3.8C deletion of amino acid 200-211 
(pC.33Kd6a) or amino acid 230-240 of 33K (pC.33Kd6c) did not abolish the 
transactivation of MLP. However, deletion of amino acid 204-231 (pC.33Kd6b)  
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Fig. 3.7. Transactivation of MLP by 33K.      (A)  Schematic representation of plasmids 
DNAs. The thin lines represent deleted sequences. Numbers above the bars denote 
residue numbers of BAdV-3 33K. The name given to each plasmid is shown on the right.  
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Fig. 3.7. Transactivation of MLP by 33K.   (B) Luciferase assay. Monolayers of HeLa 
cells were transfected with pMLP.Luc or pE1A.Luc plasmid alone or together with 
indicated individual plasmid DNAs. The cells were collected 48 hrs post transfection and 
analysed for luciferase activity.  Values are expressed as relative light units (RLU).  
Relative luciferase units (means from three independent experiments) are represented 
with corresponding standard deviations.  Presence of 33K activated the MLP resulting in 
luciferase expression that was significantly higher than pGL-MLP alone.  The statistical 
differences (P < 0.05) are indicated by letters at the top of each bar.  B is different than A; 
C, D are different than A and E; no difference between Cand D, A and E; No difference 
between F and G.  
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Fig. 3.8. Identification of transactivation domain of 33K. (A). Schematic 
representation of plasmid DNAs. The thick bars represent coding sequences for BAdV-3 
33K. The thin lines represent deleted sequences. Numbers above the bars denote amino 
acid numbers for BAdV-3 33K. The name given to each protein is shown on the right. 
(B) Western blot. Proteins from the lysates of  BAdV-3 infected MDBK or plasmid DNA 
transfected 293T cells were separated by 10% SDS-PAGE, transferred to nitrocellulose 
membrane  and probed with anti-33Kp serum The position of the molecular weight 
markers (M) in kDa is shown to the left of the panel.  
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Fig. 3.8. Identification of transactivation domain of 33K. (C)  Luciferase assay. 
Monolayers of Hela cells were transfected with pMLP.Luc  together with indicated 
individual plasmid DNAs. The cells were collected 48 h post transfection and analyzed 
for luciferase activity.  Values are expressed as relative light units (RLU).  Relative 
luciferase units (means from three independent experiments) are represented with 
corresponding standard deviations. The statistical differences (P < 0.05). are indicated by 
letters at the top of each bar. B is different than A or C; D is different from A)  
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significantly reduced the transactivation of MLP. These results suggest that amino acid 
204-231 of 33K are involved in transactivation of MLP. 
 
3.4 Discussion 
The L6 region of BAdV-3 encodes non-structural (33K and 100K) and  structural  
(pVIII) proteins (Reddy et. al, 1998).  Earlier, we reported that BAdV-3 33K detected as 
three proteins of 42, 38 and 33kDa in infected cells appear to be required for capsid 
assembly and efficient DNA capsid interaction (Kulshrestha et al., 2004). However, 
recent report suggest that 33K and 22K proteins are produced from spliced and unspliced 
forms of L4 transcripts of HAdV-2, respectively (Ostapchuk et al., 2006).  Since little is 
know about the existence of different forms of 33K in BAdV-3 infected cell, we sought 
to analyze this in detail.  Here, we report further characterization, cellular distribution and 
putative functions of 33K protein produced from spliced L6 mRNA of BAdV-3. 
Analysis of our earlier data (Kulshrestha et al., 2004) suggested that antisera, 
generated against C-terminus 197 amino acids of putative 22K protein could recognize 
both 33K and 22K proteins in BAdV-3 infected cells. Thus, reduced formation of mature 
virions in mutant BAdV-3 infected cells (Kulshrestha et al., 2004) could be due to 
inactivation of both 33K and 22K proteins. The present report confirm that  both spliced 
and unspliced mRNAs encoding 33K and 22K proteins, respectively also could be 
detected in BAdV-3 infected cells. The spliced and unspliced mRNA are predicted to 
encode proteins of 279 and 274 amino acids respectively. Similar spliced and unspliced   
mRNAs encoding 33K and 22K respectively, have been detected in other adenoviruses 
(Ostapchuk et al., 2006; Ali et al., 2007). 
Although 33K mRNA is predicted to encode a protein of 279 amino acids, 33K 
specific antisera detected five major proteins of 42 kDa,  39 kDa, 37 kDa, 21 kDa 
(appears doublet) and  19 kDa, and three minor proteins of 35 kDa, 25 kDa and 23 kDa. 
It is possible that different forms of 33K are generated by different mechanisms including 
translation from different ATG codons and by alternate splicing. Analysis of our data 
suggests that 25 kDa protein appears to be translated from third ATG (amino acid 87). 
Similarly 39 kDa protein appears to be generated by alternative splicing. Although we 
have not detected such mRNA in BAdV-3 infected cells, such rare mRNA has been 
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detected in HAdV-5 infected cells (Tormanen et al., 2006). 
Anti-22Kp serum detected three proteins of 41 kDa, 39 kDa and 37 kDa in  BAdV-3 
infected cells. Surprisingly, anti-22Kp serum did not detect such proteins in cells 
transfected with 22K expression plasmid. It is possible that 22K expressed in transfected 
cells is translated from a spliced mRNA. Several observations support this prediction. 
First, anti-33Kp detects a protein of 39 kDa in cells transfected with 22K expression 
plasmid. Secondly, similar protein of 39 kDa is detected in cells transfected with 22K 
expression plasmid containing insertion of a stop codon in the region spliced out in 33K. 
Third, anti-22Kp serum detects proteins of 39 kDa and 37 kDa in cells transfected with 
22K expression plasmid containing mutated splice accepter/ donor sites but not in cells 
transfected with 22K expression plasmid. Fourth, as expected anti-22Kp serum did not 
detect any protein in cells transfected with 22K expression plasmid containing mutated 
splice acceptor /donor sites and stop codon in the region spliced out in 33K. Earlier, 
conflicting observations have been reported regarding 22K of HAdV-5 (Ostapchuk et al., 
2006). It has been suggested that different molecular weight 22K could be detected due to 
anomalous migration of proteins in SDS-PAGE (Jansen-Durr et al., 1989; Ostapchuk et 
al., 2006). Since 22K specific antisera has not been used to determine the molecular 
weight(s) of 22K protein(s) in HAdV-5 infected cells (Ostapchuk et al., 2006), we believe 
that like BAdV-3, different forms of 22K are expressed in the HAdV-5 infected cells.                                      
The 33K proteins are detected predominantly in the nucleus of BAdV-3 infected 
cells. Although proteins less than 40 kDa in size can diffuse passively into the nucleus 
(Pante and Aebi, 1996), it is unlikely that BAdV-3 33K protein enters nucleus by simple 
diffusion mechanisms. Support for this comes from the fact that EYFP (a cytoplasmic 
protein) fused to 33K is predominantly localized to the nucleus of infected cells. 
Secondly, nuclear transport by diffusion mechanism is expected to result in equal 
distribution of the protein throughout the cell rather than accumulating in the nucleus.  
Analysis of mutant BAdV-3 33K proteins demonstrated that amino acid 201-240 
contain potential NLS, which was sufficient to transport predominantly cytoplasmic 
GFP/β-galactosidase fusion protein. Interestingly, this protein domain contains a pseudo 
RS domain (three RS motifs and one SR motif; Fig.  3.9). The RS domain of proteins has 
been shown to be involved in splicing (Caceres et al., 1994; Cazalla et al. 2002; 
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Hamelberg et  al, 2007). Interestingly, observed RS motifs are conserved in HAdV-5 33K 
and are suggested to be involved in activating IIIa splicing (Tormanen et. al, 2006). 
The RS domain has been demonstrated to act as a NLS and is solely responsible for 
nuclear localization of SR proteins (Caceres et al., 1994; Cazalla et al., 2002; Hamelberg 
et al, 2007). The nuclear transport is mediated by interaction with SR protein specific 
nuclear import receptor (Lai et al., 2001).  The phosphorylation of RS domain is required 
for interaction of SR proteins with SR protein specific nuclear import receptor(s) (Lai et 
al., 2000) 
Several evidences support the observation that the RS domain (Fig. 3.9) is not solely 
responsible for the nuclear localization of BAdV-3 33K protein. First, RS domain deleted 
33K is not located predominantly in the cytoplasm. Secondly, 33K protein does not 
interact with SR protein nuclear import receptor TRN SR2 (data not shown). Thirdly, RS 
domain of 33K is not phosphorylated.  Our results suggest that amino acid 201-240 
contain multiple NLS required for efficient nuclear localization of BAdV-3 33K. Earlier, 
adenovirus intermediate proteins (pIX and IVa2) have been shown to act as 
transcriptional activators for MLP, E1A and E4 promoters (Lutz and Kedinger, 1996; 
Lutz et al., 1997; Parks, 2004; Rosa-Calatrava et al., 2001).  Similarly, BAdV-3 33K 
appears to act as a transcriptional activator for MLP as it shows significant increase in the 
expression of luciferase protein when expressed in cells transfected with pMLP.Luc. In 
contrast, there was no increase in the expression of luciferase protein when BAdV-3 33K 
was expressed in cells transfected with pE1A.Luc.  Our analysis suggests that amino acid 
201 to 240 are involved in the transactivation of MLP. Viral transcription regulators can 
act a) by recognizing specific DNA sequences (Lutz et al, 1997), by interacting with 
cellular DNA binding proteins, and \ or   c) by acting as cellular co-factors (Lutz and 
Kedinger, 1996; Perez-Romero et al., 2005).  It is possible that 33K transactivates MLP 
by recognizing sequences unique to MLP. Alternatively, it is possible that 33K (provides 
transactivation function) binds to other cellular protein (provides specific DNA binding 
function) with a specific DNA binding activity. Further experiments are needed to prove 
these speculations.  
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1   MKP------RSMSAAGPSAAQASEGQQLPPQTAGLQPSK-RAVRKVVASLNPTAALEDI- BAdV-3 
1   MSS------KEM------------------------------------------------ CAdV-2 
1   MAP------K-------------KKLQLPPP--------------------PPTDEEEYW HAdV-2 
1   MAP------K-------------KKLQLPPPPTDEEEYW-------------DSQAEEV- HAdV-5 
1   MPPLRRKPIRSSTSTSSSRATAAATTAPATQTVSEASSTPTAVRPVPPA---TLSLADA- PAdV-3 
1   -MP------RSKKLAAATR----------PSSLNLTNPK-LKKPKLPQTPPPTPEEEDT- OAdV-7 
1   ------------------MSQRRENKKLK-----VQPPP-P---------------EDM- HAdV-35 
 
53  -SEGEEGFPLTDE--EDG--DTLE--SDFSD-----FTDEDVEEEDMISIPRDQGHS—G- BAdV-3 
 7  ---------------EDT--ETLS--VE----------DISGSEEDLESLPESMPEQ—S- CAdV-2 
22  DSQAEEVLDEEEEMMEDW--DSLDEASEAEE-----VSDETPSPSVAFPSPAPQKLA—T- HAdV-2 
28  -LDEEEEDMMEDW--ESL--DEEA--SEVEE-----VSDETPSPSVAFPSPAPQKSATGS HAdV-5 
57  -LPEEPTPAMLLE--EEA--LSSE--TSGSSEGSLLSTLEELEEE--------------- PAdV-3 
42  -MESFVEDIEEEW--DDV--DSLE--THGSG-----LEDVDLEDGETLDSPPSE------ OAdV-7 
21  -EEDWDSQAEEAE--EDSLEDSLE--EDSLE-----EENEEAEEVEEVTADKQLSSA—A- HAdV-35 
 
99  --ELEEGEIPATVAATAVKKGQGKKSRWDQ---QVRSTAPLKGAR-DPKLTKTATQSKKS BAdV-3 
36  --EMSEERAP----------------RWDQ---KEKPLAKQKLKR--------------- CAdV-2 
73  VPSIATTSAPQAPPALPVRR---PNRRWDT---TGTRAAPTAPAA—-AAAAATAAVTQKQ HAdV-2 
76  --SMATTSAPQAPPALPVRR---PNRRWDTTGTRAAHTAPAAAA-----AAATAAATQKQ HAdV-5 
95  ----EEPVTPTRPSKPSYTNSSSSKSI-SQ---RRNSVVPSEARRWNQTSIHRSSQPAIS PAdV-3 
84  -------NIPPAPKTTKA----SKQRRWDQ--------TSVTGKA-QKKLGKTLTPS--- OAdV-7 
69  --ETSNS---ATISAPSRGTRRRPSSRWDE---TGRFPNPTSASK-TAPTIASKSRQSRQ HAdV-35 
 
153 RRSASAARPRPPPLPPKRARAPRRPKGQRHQADDASTEGRDKLREL---IFPTLYAIFQQ  BAdV-3 
 60 ---------RPTPL-----------KGPKPAAGEDNHQTR-QLRNR---LFPTLYAIFQQ  CAdV-2 
125 RRPDSKTLTK----PKKSTAAAAAGGGALRLAPNEPVSTRE-LRNR---IFPTLYAIFQQ  HAdV-2 
126 RRPDSKTLTK----PKKSTAAAAAGGGALRLAPNEPVSTRE-LRNR---IFPTLYAIFQQ  HAdV-5 
147 RKAAAAAAAEPAHVSQLRAK-----------------------------IFPTLYAIFQQ  PAdV-3 
121 --FSTSTEPA------------------------ATQELRAK-------IFPTLYAIFQQ  OAdV-7 
120 IKTAAATSNRKPAAAVRKYTTSAATGGLKITANEPA-----QTRELRNRIFPTLYAIFQQ  HAdV-35 
 
210 SRAQRCHLKVKNRSLRSLTRSCLYHNKEEQLQRTLADSEALLSKYCSAA-PTRF---SPP BAdV-3 
 96 SRGSPTALKIKNRSLRSLLRSCLYHKSEEQLLRTRNDAEALLNKYC-------------- CAdV-2    
177 SRGQEQELKIKNRSLRSLTRSCLYHKSEDQLRRTLEDAEALFSKYC-------------- HAdV-2 
178 SRGQEQELKIKNRSLRSLTRSCLYHKSEDQLRRTLEDAEALFSKYC-------------- HAdV-5 
178 SRGGQDALKIRNRTLRSLTKSCLYHREEAKLERTLSDAEALFEKYCARQRQTRRYLRSGP PAdV-3 
148 SRGQKTNLKIKNRTLRSLTKSCLYHKQESQLQRTLEDAEALLQKYCS-----SL---SLP OAdV-7 
175 SRGQEQELKIKNRSLRSLTRSCLYHKSEDQLQRTLEDAEALFNKYC-------------- HAdV-35 
 
 
266 SYTESPAKDESGPA------------------------------------  BAdV-3 
142 ------QGLESGTD------------------------------------  CAdV-2 
223 ---ALTLKD-----------------------------------------  HAdV-2 
224 ---ALTLKD-----------------------------------------  HAdV-5 
238 CVRTHHEQTNPHPVHVVLSATIWACRRCLRRLLHPHELAQCRAFHDWPGQ  PAdV-3 
200 TYSSA---------------------------------------------  OAdV-7 
221 ---ALTLKE-----------------------------------------  HAdV-35 
 
 
Fig. 3.9. Amino acid homology of BAdV-3 33K like proteins. Alignment of deduced 
amino acid sequences of BAdV-3 33K homologs with those of CAdV-2 (GeneBank 
Accession # AC_000020), HAdV-2 (GeneBank Accession # AC_000007), HAdV-5 
(GeneBank Accession # AC_000008), PAdV-3 (GeneBank Accession # AC_000009), 
OAdV-7 (GeneBank Accession # NC_004037), and HAdV-35 (GeneBank Accession # 
AC_000019). The potential RS domain is overlined. Conserved amino acid regions are 
shaded. Leucine residues of potential leucine zipper are marked by filled circle.  
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The leucine zipper motif has been shown to be essential for a) protein dimerization, 
required for DNA binding (Landschulz et al., 1988), b) transactivation, and repression of 
viral proteins (Goodwin et al., 2000), and c) protein-protein interaction and 
transactivation (Geisberg et al., 1994; Sanchez et al., 2000). Analysis of 33K proteins of 
different animal and human adenoviruses revealed a highly conserved domain located 
between amino acids 195 to 255 of BAdV-3 (Fig. 3.9). Moreover, this conserved domain 
contains a leucine zipper motif (amino acids 217-240; Fig.3.9), which may help in 
dimerization of 33K required for DNA binding. Analysis of mutant BAdV-3 33K 
proteins demonstrated that deletion of amino acids 213-232, which disrupts the leucine 
zipper motif are critical for transcriptional activity of 33K. Further experiments are 
needed to prove the importance of specific residues of leucine zipper motif in DNA 
binding and transcriptional activation of MLP. 
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4.0 INTERACTION OF BOVINE ADENOVIRUS-3 33K PROTEIN WITH 
OTHER VIRAL PROTEINS 
 
 
4.1 Introduction 
Adenoviruses contain a non-enveloped, double-stranded DNA genome, which is 
organized into complex transcriptional units comprising of early, intermediate and late 
regions in members of genus Mastadenovirus (Russell, 2000). Expression of the early 
and intermediate transcription units precedes the onset of viral DNA replication. 
However, expression of the late transcription unit is dependent on the initiation of viral 
DNA replication and depends on the expression of the major late transcription unit 
(MLTU), which is controlled by the major late promoter (MLP) (Thomas and Mathews, 
1980).  
We have been carrying out molecular characterization of bovine adenovirus 
(BAdV) 3 (Lehmkuhl et al., 1975) with the aim of developing it as a vaccine delivery 
vehicle for animals and humans (Rasmussen et al., 1999; Tikoo, 2001; Kulshreshtha et al., 
2004; Xing and Tikoo, 2007). Like other members of Mastadenovirus, the BAdV-3 
genome is organized into early, intermediate, and late regions (Reddy et al., 1998). The 
late region of BAdV-3 genome is organized into seven regions L1–L7 (Reddy et al., 
1998). The L6 region of late transcription unit of BAdV-3 encodes 33K and 22K protein 
(Reddy et al., 1998; Kulshreshtha et. al, 2004). The L6 33K protein is a product of a 
spliced transcript, while 22K protein is translated from the unspliced form of this 
transcript (Reddy et. al, 1998; Kulshrestha and Tikoo, unpublished data).  The 33K and 
22K proteins share the N-terminus region of 138 amino acids (Chapter 3.0).  
Adenovirus 33K protein acts as an alternative RNA splicing factor (Tormanen et 
al., 2006) and a transcriptional activator (Ali et al., 2007), and plays a role in viral capsid 
assembly as well as efficient capsid DNA interaction (Fessler and Young, 1999; Finnen 
et al., 2001; Kulshreshtha et al., 2004). Recently, adenovirus 22K protein has been shown 
to be involved in the packaging of adenovirus genome (Ostapchuk et al., 2006). The 
conservation of 33K protein in Mastadenoviruses together with its multiple functions in 
the adenovirus life cycle suggests that 33K might be involved in the interaction with 
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other viral or cellular proteins. In this report, we demonstrate that 33K interacts with 
100K and protein V (pV) during the course of BAdV-3 infection. 
 
4.2 Materials and methods 
4.2.1 Cell lines and virus 
  Madin-Darby bovine kidney (MDBK) cells were cultured in minimal essential 
medium (MEM) with 10% fetal bovine serum (FBS). The wild-type BAdV-3 was 
cultivated in MDBK cells as described previously (Reddy et al., 1999). 
 
4.2.2 Antibodies 
Production and characterization of antibodies specific to BAdV-3 33K protein 
have been described earlier (Kulshreshtha et al., 2004). Details concerning the production 
of antibodies specific to 100K and pV will be described elsewhere. Briefly, anti-100K 
raised against synthetic peptides recognizes a protein of 130 kDa in BAdV-3 infected 
cells, while anti-pV serum raised against synthetic peptides recognizes a protein of 56 
kDa in BAdV-3 infected cells. 
 
4.2.3 Plasmid construction 
The plasmid vectors were constructed as per standard procedures using the DNA 
modifying enzymes and restriction enzymes (Sambrook and Russell, 2000). 
A) Construction of yeast expression plasmids.  Individual BAdV-3 genes acting as bait or 
prey were PCR amplified using specific primer sets (Table 4.1) and plasmid pFBAV302 
(Zakharcthouk et al., 1998) DNA as a template. The appropriate PCR amplified DNA 
fragments were digested with restriction enzymes (Table 4.1) and ligated to restriction 
enzyme digested plasmids pGBKT7 or pGADT7 (Clontech: Table 4.1). 
i) Construction of p33Kd1. A 213 bp fragment was amplified by PCR using primers 
P1and P2 (Table 4.2), and plasmid pGBK-33K DNA as a template. Similarly, a 1000 bp 
fragment was isolated by PCR using primers P3 and P4 (Table 4.2), and plasmid pGBK-
33K DNA as a template. In a third PCR reaction, both amplified fragments were annealed 
and external primers P1 and P4 (Table 4.2) were used to PCR across to give a final 1.2 kb 
amplicon. This PCR product was digested with NdeI- EcoRI and ligated to NdeI- EcoRI 
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digested pGBKT7 creating plasmid p33Kd1.   
ii) Construction of p33Kd2. A 7.9 kb SacII-AatII fragment of plasmid pGBKT7-33K 
was isolated and ligated to oligos O1 and O2 (Table 4.2) to create plasmid p33Kd2.  
iii) Construction of p33Kd3. A 235 bp fragment was amplified by PCR using primers 
P5 and P6 (Table 4.2), and plasmid pGBK-33K DNA as a template. Similarly, a 500 bp 
fragment was isolated by PCR using primers P7 and P4 (Table 4.2), and plasmid pGBK-
33K DNA as a template. In a third PCR reaction, both amplified fragments were annealed 
and external primers P5 and P4 (Table 4.2) were used to PCR across to give a final 735 
bp amplicon. This PCR product was digested with NdeI- EcoRI and ligated to NdeI- 
EcoRI digested pGBKT7 creating plasmid p33Kd3.   
iv) Construction of p33Kd4. A 360 bp fragment was amplified  by PCR using primers 
P5 and P8 (Table 4.2), and plasmid pGBK-33K DNA as a template. Similarly, a 375 bp 
fragment was isolated by PCR using primers P9 and P4 (Table 4.2), and plasmid pGBK-
33K DNA as a template. In a third PCR reaction, both amplified fragments were annealed 
and external primers P5 and P4 (Table 4.2) were used to PCR across to give a final 735 
bp amplicon. This PCR product was digested with NdeI- EcoRI and ligated to NdeI- 
EcoRI digested pGBKT7 creating plasmid p33Kd4.   
v) Construction of p33Kd5. A 490 bp fragment was amplified by PCR using primers 
P5 and P10 (Table 4.2), and plasmid pGBK-33K DNA as a template. Similarly, a 850 bp 
fragment was isolated by PCR using primers P11 and P12 (Table 4.2), and plasmid 
pGBK-33K DNA as a template. In a third PCR reaction, both amplified fragments were 
annealed and external primers P5 and P4 (Table 4.2) were used to PCR across to give a 
final 735 bp amplicon. This PCR product was digested with NdeI- EcoRI and ligated to 
NdeI- EcoRI digested pGBKT7 creating plasmid p33Kd5.   
vi) Construction of p33Kd6. A 610 bp fragment was amplified by PCR using primers 
P5 and P13 (Table 4.2), and plasmid pGBK-33K DNA as a template. Similarly, a 730 bp 
fragment was isolated by PCR using primers P14 and P12 (Table 4.2), and plasmid 
pGBK-33K DNA as a template. In a third PCR reaction, both amplified fragments were 
annealed and external primers P5 and P4 (Table 4.2) were used to PCR across to give a 
final 735 bp amplicon. This PCR product was digested with NdeI- EcoRI and ligated to 
NdeI- EcoRI digested pGBKT7 creating plasmid p33Kd6. 
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Gene  Primer sequence 
33K     5’GGAATTCCATATGATGAAACCCCGCAGCATGTCG       
5’-GGAATTCTTAGGCGGGTCCGGATTCG                          0.840kbΨ    pGBKT7Ψ 
100K    5’-GGAATTCCATATGATGGCAGAGAAAGGCAGTG        
5’-GGAA TTCCTACTCTTCTTGCCCTGG                             2.500kbΨ pGADT7Ψ 
52K     5’-GGAATTCCATATGATGATGCATCCCGCTTTACG 
5’-GGAATTCTCAGAATCGCCAGTGGTTAG                      1.000kbΨ      pGADT7Ψ 
pIX      5’-GGAATTCCATATGAACATGGCCGAGGAAGG 
5’-GGAATTCTTAAACAAAGGGGTTAACTTGG     0.375kbΨ pGADT7Ψ 
IVa2    5’-GGAATTCCATATGATGCTGGATGGAGATGTAC 
5’-GGAATTCTCAATAAAATTCTTTATTTTTCCTG     1.100kbΨ pGADT7Ψ 
pIII 5’-GGAATTCCATATGATGCTCCAGCCCGAACTGC 
5’-GGAATTCTTAAAACGTGCGGCTAGATAGC     1.400kbΨ    pGAD     
DBP   5’-CGGGGGTACCCATATGATGAATCGCAGCGGTGA 
5’- CGCGGATCCTTAAAACAAAGAGTCATCTGC      1.300kbΨ   pGADT7Ψ 
pV       5’-GGAATTCATGGCCTCCTCTCGGTTGATTAAA 
5’-CGGGATCCCTAGGGTGATAGCGCACGCC      1.200kbΩ   pGADT7Ω 
pVI     5’- CCGGAATTCATGGACGAATACAATTACGCG 
5’- CGCGGATCCGCGGCCGCTCAATAGCACCGCCG 
      GCG           0.791kbΩ   pGADT7Ω 
pVII      5’- CCGGAATTCATGCGTTTTAATCTGGGCAG 
5’- CGCGGATCCGCGGCCGCTCAGAGGCCCACG 
     ATG TCATTC                                         0.520kbΩ      pGADT7Ω  
pTP    5’- CCGGAATTCATGTTTTTTGCAGAGCGCG 
5’- CGCGGATCCGCGGCCGCTTAAAGGGGACGTC 
     GAGG         1.900kbΩ    pGADT7Ω 
pX     5’- CCGGAATTCATGAGTCCCCGCGGAAATC 
5’- CGCGGATCCCTCGAGCTATTTGTTGTGGGCC 
     GCC         0.245bpΩ  pGADT7Ω 
_______________________________________________________________________________ 
Table 4.1: List of primers used in the construction of yeast plasmids 
PCR Fragment Ligated to 
  plasmid 
Restriction enzyme sites are underlined; Ψdigested with NdeI-BamHI;  
Ωdigested with EcoRI-BamHI; 
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Table 4.2: List of primers used in the construction of 33K deletions 
 Primer     DNA Sequence 
 
 
 
 
 
 
 
 
 
 
 
P1    5’-GATGCCGTCACAGATAGATAGATTG-3’ 
P2   5’-CATCATATGCAGGTCCTCCTC-3’ 
P3   5’-GCTTCTCTGAATCCCACCGC-3’ 
P4   5’-GGAATTCTTAGGCGGGTCCGGATTCG-3’ 
P5    5’-GGAATTCCATATCATGAAACCCCGCAGCATGTCG-3’ 
P6   5’-CCTACTCTTGTCCGTGAAGTCGCTGAAA-3’ 
P7    5’-TTCACGGACAAGAGTAGGTGGGACCAGC-3’ 
P8    5’-AGGGCGAGGCTTGCCCTGGCCCTTCTTG-3’ 
P9    5’-CAGGGCAAGCCTCGCCCTCCTCCTCTT-3’ 
P10    5’-GAGAGTGGGCGCGCTGGCACTCCGC-3’ 
P11    5’-GCCAGCGCGCCCACTCTCTATGCCATAT-3’ 
P12    5’-GAGTGAGCTGATACCGCTC-3’ 
P13    5’-GGTTCGCTGAAAGATCAGCTCCCGAAGCTT-3’ 
P14    5’-CTGATCTTTCAGCGAACCCTAGCAGACT-3’ 
P17    5’-GGCGGGTCCGAGCTGTTCCTCCCTTGTTGT-3’ 
P18    5’-GAACAGCTCGGACCCGCCTAAGAATTCC-3’ 
P19    5’-GGAATTCTTAGGCGGGTCC-3’ 
O1    5’-GGCTCAGGCTTCGGAGGGCCAACAGCTGCCGC 
                 CACAGACAGCGGGGCTGCAGCCGAGCAAGAGG-3’ 
O2   5’-CTACTACCTTCCTCACAGCCCTCTTGCTCGGCTG 
                  CAGCCCCGCTGTCTGTGGCGGCAGCTGTTGGCC 
                                      CTCCGAAGCCTGAGCCGC-3’ 
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vii) Construction of p33Kd7. A 730 bp fragment was amplified by PCR using primers 
P5 and P17 (Table 4.2), and plasmid pGBK-33K DNA as a template. Similarly, a 620 bp 
fragment was isolated by PCR using primers P12 and P18 (Table 4.2), and plasmid 
pGBK-33K DNA as a template. In a third PCR reaction, both amplified fragments were 
annealed and external primers P5 and P19 (Table 4.2) were used to PCR across to give a 
final 735 bp amplicon. This PCR product was digested with NdeI- EcoRI and ligated to 
NdeI- EcoRI digested pGBKT7 creating plasmid p33Kd7.   
B) Construction of plasmid pGADT7 plasmids. A 375 bp fragment (pIX ORF), 1.1 kb 
fragment (IVa2 ORF) and 1kb fragment (52K ORF) and were isolated by PCR 
amplification [using specific primers (Table 4.1) and plasmid pFBAV302 DNA as a 
template], digested  with NdeI-EcoRI and individually ligated to 7.9 kb NdeI-EcoRI 
digested plasmid pGADT7 creating plasmids pGADT7-pIX, pGADT7-pIVa2 and 
pGADT7-52K, respectively. Similarly, a 1.2kb fragment containing pV was isolated by 
PCR amplification [using specific primers (Table 4.1) and plasmid pFBAV302 DNA as a 
template] digested with EcoRI-BamHI and ligated to EcoRI-BamHI digested plasmid 
pGADT7 creating plasmid pGADT7-pV. 
C) Construction of plasmids pGEX plasmids.  A 830 bp NdeI-EcoRI fragment containing 
spliced 33K gene excised from plasmid pGBKT7-33K was blunt end repaired with T4 
DNA polymerase and ligated to SmaI digested plasmid pGEX-5X-1 to create plasmid 
pGEX-33K. A 1.2 kb EcoRI-BamHI fragment containing pV gene, excised from plasmid 
pGADT7-pV, was blunt end repaired with T4 DNA polymerase and ligated to SmaI 
digested plasmid pGEX-5X-1 to create plasmid pGEX-pV. Similarly, a 2.5 kb NdeI-
EcoRI fragment containing 100K gene excised from plasmid pGBKT7-100K was blunt 
end repaired with T4 DNA polymerase and ligated to SmaI digested plasmid pGEX-5X-1 
to create plasmid pGEX-100K. 
 
4.2.4 Yeast two hybrid system 
  The Matchmaker two hybrid systems 3 using Saccharomyces cerevisiae 
(Clontech) was used to detect the interactions between 33K protein and other viral 
proteins. These interaction studies involved the use of yeast expression plasmids 
pGBKT7 (bait plasmid) and prey plasmid pGADT7 (Clontech). The bait and prey 
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constructs were co-transformed in the yeast strain AH109 as per Clontech protocol and 
grown on the SD/-Leu/-Trp medium (low stringency selection) at 30°C to select the DNA 
BD and AD plasmid DNAs. These co-transformants were further screened for HIS3 
expression by growing transformed yeast on SD/-Leu/-Trp/-His medium (medium 
stringency selection). Subsequently, the His positive colonies were further screened for 
ADE2 and MEL1 expression by growing on high stringency selection medium (SD/-
Leu/-Trp/-His/-Ade/X-alpha-Gal). 
 
4.2.5 GST pulldown assays 
  The plasmids pGEX-5X-1, pGEX-33K , pGEX-pV and pGEX-100K were 
individually transformed in E. coli BL21 cells. The GST alone, GST-33K and GST-100K 
fusion proteins were induced by 0.25mM isopropyl-β-D-thiogalactopyranoside (IPTG) 
(Gibco-BRL) and immobilized on Glutathione-Sepharose beads (Pharmacia) as described 
elsewhere (Zhou and Tikoo, 2001). The identities of the proteins were analyzed by 
Western blot using anti-GST serum.  
Plasmid DNA (pGADT7-V, pGADT7-100K, pGBKT7-33K, p33Kd3, p33Kd4 or 
p33Kd5), were in vitro transcribed and translated using TNT T7 quick-coupled 
transcription / translation kit (Promega) in the presence of 30 μCi of [35S]methionine. For 
in vitro binding, 10μg of GST or GST-33K  fusion protein on Glutathione-Sepharose 4B 
beads was incubated with 5μl of in vitro translated pV (pGADT7-V) or 100K (pGADT7- 
100K) proteins in a final volume of  500μl of binding buffer (30mM Hepes pH 7.4, 
50mM KCL, 0.5% Tween 20, 0.5% non fat dry milk, 2mM PMSF). Similarly,  10μg of 
GST or GST-100K fusion on Glutathione-Sepharose 4B beads was incubated with 5μl of 
in  vitro translated protein 33Kd3 (p33Kd3), 33Kd4 (p33Kd4) in a final volume of 500 μl 
of binding buffer. After incubating at 4°C for 4 hours with rotation, the beads were then 
washed four times with the binding buffer. The bead bound proteins were separated by 
SDS-PAGE and analyzed by autoradiography. 
 
4.2.6 In vitro translation  
Plasmid DNA (pGADT7-pV, pGBKT7-33K, pGBKT7-33Kd2 or pGBKT7-
33Kd3) were in vitro transcribed and translated using TNT T7 quick coupled 
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Transcription / Translation kit (Promega). Equal amounts of non labeled proteins were 
mixed at 40C for 4-6 h. Proteins were immunoprecipitated with protein specific serum, 
separated by sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) 
and transferred to nitrocellulose membranes.  The separated proteibns were probed by 
Western blot as described (Kulshrestha et al., 2004) using protein specific antisera. 
4.2.7 Immunoprecipitation / Western blotting 
Madin Darby bovine kidney (MDBK) cells infected with wild-type BAdV-3 at an 
MOI of 5 were harvested at 36 hrs post-infection. The infected cells lysed with triton 
lysis buffer (1% Triton X-100, 10 mM HEPES [pH 7.4], 2 mM EDTA, 2 mM sodium 
orthovanadate, 0.1% β-mercaptoethanol, protease inhibitors[2mM PMSF and 1 µg each 
of leupeptin and pepstatin per ml]) were incubated overnight at 4oC with preimmune 
serum, anti-pV serum or anti-100K serum. The protein A agarose bead were then added 
and mixtures were incubated for another 4 hrs at 4°C, before washing the beads  four 
times with lysis buffer. After addition of 2X SDS-sample buffer, beads were boiled for 
two minutes, subjected to SDS-PAGE and transferred to Immobilon-P membrane 
(Millipore Corporation). Finally, the membrane was probed with anti-33K serum and 
visualized by treating the membrane with BCIP/NBT solution (Sigma). Similarly, BAdV-
3 infected cell lysates were immunoprecipitated with preimmune serum as well as anti-
33K serum and probed with anti-pV serum as well as anti-100K serum.  
 
4.3 Results 
 4. 3.1 Yeast two hybrid system 
 To identify the interactions of 33K protein with other viral proteins, matchmaker 
GAL4 yeast two hybrid system was used. In this system, the bait and prey plasmids are 
co-transformed in the yeast and the resulting interaction between bait and prey proteins, 
are identified by the transcriptional activation of reporter genes like ADE2, HIS3, lacZ. 
The RT-PCR amplified 33K was fused in-frame to the GAL4 DNA binding domain (aa 
1–147) of pGBKT7 and used as a bait (Table 4.1). The PCR amplified late viral genes 
were fused in frame to the GAL4 activation domain (aa 768–881) in the prey vector 
pGADT7 and used as a prey (Table 4.1).  These constructs were analyzed by restriction 
enzymes analysis of DNA and confirmed to be in-frame by DNA sequencing. 
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Both the pGBKT7- and the pGADT7- derived constructs were co-transformed in the 
yeast and the interactions were screened though medium and high selection stringencies 
(Singh et al. 2005). Interaction between two proteins led to the activation of genes, which 
allowed the growth on media lacking histidine (His) and adenine (Ade) (Singh et al., 
2005) The higher stringency selection revealed the blue colonies upon co-transforming 
pGBKT7-33K along with pGADT7- pV or pGADT7-100K (Fig 4.1). No blue colonies 
were observed on co-transforming pGBKT7-33K and pGADT7 plasmid in the yeast. 
These findings suggest that 33K protein may be specifically interacting with pV and 
100K protein. 
To identify the domains of 33K protein involved in these interactions, we constructed 
plasmids containing deletions in 33K ORF (Fig 4.2A) cloned individually in pGBKT7 
plasmid. These deletions were analyzed by restriction enzyme analysis of DNA, DNA 
sequencing and by Western blot for expression of mutant 33Kd1 to 33Kd7 proteins (Fig. 
4.2B). These pGBKT7 plasmids containing 33K deletions were used as bait with plasmid 
pGADT7-pV or pGADT7-100K as a prey in yeast two hybrid assays.  Blue colonies were 
only observed when mutant 33K interacted with the prey.  As seen in Fig. 4.3, all mutant 
33K proteins except 33Kd3 (amino acid 81-120 deleted) interacted with pV. These 
results suggest that the deletion of amino acid 81-120 of 33K disrupted the interaction of 
33K with pV. Similarly, all mutant 33K proteins except 33Kd4 (aa 121-160 deleted) and 
33Kd5 (aa160-200 deleted) interacted with 100K (Fig 4.3). These results suggested that 
the deletion of amino acids 121-200 of 33K disrupted the interaction of 33K protein with 
100K protein. 
 
4.3.2   33K protein interacts with protein V and 100K protein in vitro 
To confirm the results of yeast two hybrid analyses, we tested the interaction of 
proteins in vitro using GST pull down assay. The part of ORF 33K (amino acids----- 279) 
, ORF 100K  (amino acids ---- 850) or ORF pV (amino acids ---- 410) was fused in frame 
to GST in the pGEX-5X-1 plasmid creating the plasmids pGEX-33K, pGEX-100K and 
pGEX-V respectively. The GST alone, GST-33K, GST-100K or GST-V proteins were 
induced by IPTG and the expression of these proteins was confirmed by Western blot 
using anti-GST, anti-33K, anti-100K serum (Fig. 4.4) or anti- pV serum. Compared to  
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Fig. 4.1. Yeast two-hybrid analysis. Plasmid pGADT7 (prey) expressing  DBP, pVI, 
pVII, IVa2, penton, 52K, pTP, 100K, pV or pX,  and plasmid pGBKT7 (bait) expressing 
33K  were co-transformed in yeast strain AH109. The co-transformants were streaked on 
SD/Leu-/Trp-/His-/Ade-/ X-α-gal-containing plates and incubated at 30°C for 5-7 days. 
pGADT7 and AD_’T’ antigen were used as negative controls. 
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Fig. 4. 2. Analysis of mutant 33K. A) Schematic representation of BAdV-3 33K and 
mutant 33K proteins. B) Western blot. Proteins from lysates of AH109 yeast cells 
transformed with plasmid pGBKT7 (mock), plasmid pGBKT7 expressing 33K or mutant 
33K proteins were separated by 10% SDS-PAGE under reducing conditions and 
transferred to nitrocellulose. The separated proteins were probed in Western blot by anti-
33K serum. 
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Fig. 4.3. Yeast two hybrid analysis using mutant 33K proteins. Plasmids pGBKT7 
expressing 33K, 33Kd1, 33Kd2, 33Kd3, 33Kd4, 33Kd5, 33Kd6 or 33Kd7 (acting as bait) 
were cotransformed with plasmid pGADT7-100K (prey) or pGADT7-pV (prey) in 
AH109 yeast. The cotransformants were streaked on SD/Leu-/Trp-/His-/Ade-/ X-α-gal-
containing plates and incubated at 30°C for 5-7 days. 
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Fig. 4.4. Immunoblot analysis of Glutathione-Sepharose-immobilized proteins. 
Purified GST (lane 2), GST-33K (lane 4) and GST-100K (Lane 6) proteins were 
separated by 10% SDS–PAGE, transferred to Immobilon-P membrane and analyzed by 
immunoblotting using anti-GST serum (lane 1,2), anti-33K serum (lanes 3,4) and anti-
100K serum (lanes 5,6). Uninfected MDBK cell lysates (lanes 1,3,5) were used as  
negative controls. The position of the molecular weight markers (M) in kDa is shown to 
the left of the each panel. Arrows on the right of each panel indicate the position of the 
identified protein. 
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other fusion proteins, multiple bands of GST-V fusion protein were detected (data not 
shown). These results suggested that GST-pV fusion protein is not stable.  The induced 
GST-100K and GST-33K fusion proteins were bound on glutathione sepharose beads as 
per described (Zhou and Tikoo, 2001).  
The  plasmids  pGADT7-pV, pGADT7-100K, pGBKT7-33K, p33Kd3, p33Kd4 or 
p33Kd5 containing T7 promoter upstream of protein coding regions were individually 
transcribed and translated in- vitro in the presence of 50 μl of [35S] methionine, using 
TNT T7-coupled reticulocyte lysate system as described by the manufacturer (Promega).  
The GST-fusion proteins bound to glutathione sepharose beads were individually 
incubated with in-vitro translated [35S]-labeled proteins for 6 h at 4oC. After extensive 
washing with binding buffer, the bead bound products were separated on 10% SDS- 
PAGE and visualized by autoradiography. As seen in Fig. 4.5A, in vitro translated  pV   
interacted with GST-33K protein (Lane 2). Similarly, in vitro translated 100K protein 
interacted with GST-33K protein (Fig. 4.5B, lane 2). No interaction was detected 
between in vitro synthesized pV (Fig. 4.5A) or 100K (Fig. 4.5B) with GST protein alone 
(Lane 1) demonstrating the specificity of the assay. These results confirm the yeast two 
hybrid observations and suggest that 33K/pV and 33K/100K interactions are real. 
To confirm the domain of 33K protein involved in the interaction with 100K protein, 
GST pull down assay was carried out as described above. As seen in Fig. 4.6, GST-100K 
fusion protein interacts with 33K, 33Kd3 and 33Kd4 proteins. No such interaction was 
observed between GST-100K and mutant 33Kd5 protein (Fig 4.6). These findings 
confirm the in vivo yeast screening analysis and suggest that 161-200 amino acid domain 
of 33K protein may be involved in the interaction with 100K protein. 
Since GST-pV fusion protein was unstable, we carried out an in vitro co-
immunoprecipitation assay to determine the domain of 33K interacting with pV. The pV, 
33K and 33K mutant proteins were translated in vitro as described above. For co-
imunoprecipitation assay, in vitro translated pV was incubated with in vitro translated 
33K , p33Kd3 or p33Kd4   for 6 h at 4oC before immunoprecipitation with anti-pV 
serum. The co-immunoprecipitated proteins were separated on 10% SDS-PAGE under  
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Fig. 4. 5. GST pulldown assay. (A) Purified GST alone (lane 1) or GST-33K (lane 2) 
proteins immobilized on Glutathione-Sepharose 4B beads, incubated with in vitro  
translated [35S] labeled pV, were separated by 10% SDS–PAGE and detected  by 
autoradiography. Lane 3 indicates in vitro translated [35S] methionine labeled  pV. (B) 
Purified GST alone (lane 1) or GST-33K (lane 2) proteins immobilized on Glutathione-
Sepharose 4B beads, incubated with in vitro translated [35S] methionine labeled 100K 
protein, were separated by 10%  SDS–PAGE and detected by autoradiography. Lane 3 
indicates in vitro translated [35S] methionine labeled 100K Protein. The position of the 
molecular weight markers (M) in kDa is shown to the left of the panel. Arrows on the 
right of each panel indicate the position of the identified protein in kDa.   
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Fig. 4. 6. Binding of labeled proteins to GST-fusion proteins. (A) Purified GST or 
GST-100K proteins were immobilized on glutathione-Sepharose 4B beads, incubated 
with in vitro translated  [35S] methionine labeled 33K, 33Kd5, 33K3d3 or 33Kd4, The 
bound proteins were separated by 10% SDS–PAGE and detected by autoradiography. 
The position of the molecular weight markers (M) in kDa is shown to the left of the 
panel. 
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reducing conditions. The separated proteins were transferred to nitrocellulose membranes 
and probed in Western blot using anti-33K serum. As seen in Fig. 4.7, pV interacts with 
mutant 33Kd4 protein but not with mutant 33Kd3 protein. These results confirmed the 
earlier observations and suggested that amino acids 81-120 of 33K are involved in the 
binding to pV.  
 
4.3.3 In vivo interaction of 33K with 100K and pV  
To confirm the interaction of 33K with 100K or pV during BAdV-3 infection, 
the coimmunoprecipitation studies were carried out in BAdV-3 infected cells using 
protein specific antibodies. Cleared lysates prepared from BAdV-3 infected cells were 
immunoprecipitated with anti-33K serum or anti-pV serum. The co-immunoprecipitated 
proteins were separated on 10% SDS-PAGE, transferred to nitrocellulose membranes and 
probed in Western blots using anti-pV serum or anti-33K serum. As seen in Fig. 4.8A, a 
56 kDa protein representing pV was observed when the infected cell lysates were 
immunoprecipitated with anti-33K serum and probed in Western blot with anti-pV serum 
(Lane 2). No such protein was observed when infected cell lysates were incubated with 
preimmune serum and probed with anti-pV serum (Lane 1). Similarly, a protein of 42 
kDa representing 33K protein was observed when infected cell lysates were 
immonprecipitated with anti-pV serum and probed in Western blot with anti-33K serum 
(Fig. 4.8B, lane 2). No such protein was observed when infected cell lysates were 
incubated with preimmune serum and probed in Western blot with anti-pV serum (Fig. 4. 
8B, Lane 1). These results suggest that 33K and pV interact specifically during BAdV-3 
infection. 
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Fig. 4.7. Co-immunoprecipitation of in vitro translated proteins.  In vitro translated 
pV protein was  incubated individually with in vitro translated  33Kd3 (lane 2) , 33Kd4  
(lane 3) or 33K (lane 4) proteins, The bound proteins were immunoprecipitated with anti-
pV serum (lane 2,3,4) or preimmune serum (lane 1) separated by 10% SDS-PAGE and 
transferred to nitrocellulose membrane. The separated proteins were probed by Western 
blot using anti-33K serum. The position of the molecular weight markers (M) in kDa is 
shown to the left of the panel. Arrow on the right of panel indicates the position of the 
identified protein in kDa.   
 
 
 
 
 
 
 
 
55 
43 
 M             1                      2                         3                      4 
 80
 
 
 
 
Fig. 4. 8. Co-immunoprecipitation of 33K and pV proteins in BAdV-3 infected cells. 
(A) Proteins from the lysates of BAdV-3 infected cells were immunoprecipitated with 
preimmune serum (lane 1) or anti-33K serum (lane 2), separated by 10% SDS–PAGE, 
and transferred to Immobilon-P membrane. The separated proteins were probed by 
Western blot using anti- pV serum. Proteins from the lysates of BAdV-3 infected cell 
were separated by 10% SDS-PAGE, transferred to Immobilon-P membrane and probed 
with anti-pV serum (lane 3). (B) Proteins from the lysates of BAdV-3 infected cells were 
immunoprecipitated with preimmune serum (lane 1) or anti -pV serum (lane 2), separated 
by 10% SDS–PAGE, and transferred to Immobilon-P membrane. Separated proteins were 
probed by Western blot using anti-33K serum. Proteins from BAdV-3 infected cell 
lysates were separated by 10% SDS-PAGE, transferred to Immobilon-P membrane and 
probed with anti-33K serum (Lane 3). The position of the molecular weight markers (M) 
in kDa is shown to the left of the panel. Arrows on the right of each panel indicate the 
position of the identified protein in kDa.  
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Similarly, a protein of 130 kDa representing 100K protein was observed when the 
infected cell lysates were immunoprecipitated with anti-33K serum and probed in 
Western blot with anti-100K serum (Fig. 4.9A, Lane 2). No such protein was observed 
when infected cell lysates were immunoprecipiated with preimmune serum and probed in 
Western blot with anti- 100K serum (Fig. 4.9A, Lane 1). Similarly, a protein of 42 kDa  
representing 33K protein was observed when the infected cell lysates were 
immunoprecipitated with anti-100K serum and probed in Western blot with anti-33K 
serum (Fig. 4.9B, Lane 2). These results suggest that 33K and 100K interact specifically 
during BAdV-3 infection.  
 
4.4 Discussion 
The 33K protein of adenovirus appears to be a multi-functional protein, which 
acts as alternative splicing factor (Tormanen et al., 2006) and plays an important role in  
viral assembly (Fessler and Young, 1999; Finnen et. al, 2001; Kulshreshtha et. al, 2004), 
stimulation of transcription from the MLP (Ali et. al, 2007)  and  early to late switch in 
MLP transcription (Farley et al., 2004).  The multifunctional role played by 33K  in 
adenovirus biology suggest that 33K may interact with other viral or cellular proteins. 
Here, we report for the first time that 33K protein interacts with 100K and pV during 
BAdV-3 infection. 
The yeast two hybrid analyses revealed that 33K protein may be interacting with pV 
and 100K proteins of BAdV-3. This initial observation is supported by the fact that these 
interactions between 33K - 100K and 33K - pV were confirmed by GST pull down assay.  
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Fig. 4.9. Co-immunoprecipitation of 33K and 100K protein in BAdV-3 infected cells. 
A) Proteins from the lysates of BAdV-3 infected cells were immunoprecipitated with 
preimmune serum (lane 1) or anti-33K serum (lane 2), separated by 10% SDS–PAGE, 
and transferred to Immobilon-P membrane. Separated proteins were probed by Western 
blot using anti-100K serum. Proteins from BAdV-3 infected cell lysates were separated 
by 10% SDS-PAGE, transferred to Immobilon-P membrane  and probed with anti-100K 
serum (lane 3) (B) Proteins from the lysates of BAdV-3 infected cells were 
immunoprecipitated with preimmune serum (lane 1) or  anti-100K serum (lane 2), 
separated by 10% SDS–PAGE, and transferred to Immobilon-P membrane. Separated 
proteins were probed by Western blot using anti-33K serum Proteins from BAdV-3 
infected cell lysates were separated by 10% SDS-PAGE, transferred to Immobilon-P 
membrane and probed with anti-33K serum (lane 3). The position of the molecular 
weight markers (M) in kDa is shown to the left of the panel. Arrows on the right of each 
panel indicate the position of the identified protein in kDa.   
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Moreover, these specific interactions between 33K-100K and 33K-pV were detected in 
BAdV-3 infected cells using co-immunoprecipitation and Western blot assays. 
The detection of specific interaction between 33K / 100K proteins and 33K/pV 
proteins in BAdV-3 infected cells suggested that such interactions have a significant role 
in the virus replication cycle. However, the exact function of these interactions during the 
viral infection is currently unclear. The 100K protein associates with hexon monomers, 
help in the formation of hexon trimers and assist in the transport of hexon trimers to the 
nucleus of baculovirus infected cells (Hodges et al., 2001). However, expression of hexon 
and 100K in transfected COS-7 cells did not transport hexon to the nucleus (Hong et  al., 
2005). It is possible that interaction of 33K with 100K stabilizes the trimerization of 
hexons and helps to efficiently transport the hexon trimers to the nucleus of BAdV-3 
infected cells. Support for this comes from the fact that despite the expression of early 
and late genes in the cells transfected with mutant BAdV-3 DNA containing insertional 
mutation in 33K of BAdV-3, the majority of hexon was detected  in the cytoplasm of the 
transfected cells (Kulshrestha et al., 2004). Moreover, the 33K function in baculovirus 
infected cells may be functionally substituted by a viral or an insect cell protein(s). 
Alternatively, it is possible that hexon trimerization and efficient nuclear import may be 
mediated by different proteins including 33K at different stages of the BAdV-3 
replication (Hong et al., 2005; Wodrich et al., 2003). Partial localization of hexon in the 
nucleus of adenovirus pVI transfected cells (Wodrich et al., 2003) or adenovirus 100K 
expressing insect cells (Hong et al., 2005) support this possibility. 
 Although adenovirus 33K protein is required for the assembly of virus particles 
(Finnen et al., 2001; Kulshreshtha et al, 2004), it can interact with adenovirus packaging 
sequence only in the presence of IVa2 protein (Ali et al., 2007). Since pV is known to 
specifically bind adenovirus genome (Ugai et al., 2007), the interaction of 33K with pV 
may help to increase the cooperative binding of 33K protein to the viral DNA packaging 
sequences. Alternatively, interaction of 33K with pV may help to relieve the repressive 
effect of pV on major late promoter activity (Ugai et al., 2007). Several lines of evidence 
support this speculation. First, significant level of 33K specific mRNAs and protein were 
detected in adenovirus infected cells before the beginning of transcription /translation of 
other late protein (Beltz and Flint 1979; Larsson et al., 1992). Secondly, 33K protein is 
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required for the efficient expression of ML transcription unit (Ali et al., 2007; Farley et 
al., 2004) Thirdly, expression of major late structural proteins was detected significantly 
earlier in mutant adenovirus containing deletion of pV (Ugai et al., 2007).  
Although the boundaries have not been fully defined, our analysis of the deletion 
mutants suggested that amino acid 81-120 and 161-200 of 33K are involved in the 
interaction with pV and 100K proteins, respectively. Nevertheless, precise localization of 
the region and the identification of mutants of 33K that prevent interaction, and 
assessment of the consequences of these mutations on virus life cycle should provide 
insights into the functional importance of these novel interactions.  Interestingly, while 
the identified region required for the interaction of 33K with pV protein is shared 
between 33K and 22K proteins, the identified region required for the interaction of 33K 
and 100K is not shared by 33K and 22K. It would be of interest to determine the role of 
each protein in these interactions. 
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5.0 INTERACTION OF BOVINE ADENOVIRUS-3 33K PROTEIN WITH 
CELLULAR PROTEINS 
 
5.1 Introduction 
Adenoviruses contain a non-enveloped, double-stranded DNA genome (Davison 
et al., 2000), which is organized into complex transcriptional units comprising of early, 
intermediate and late regions. Although expression of the early and intermediate 
transcription units precedes the onset of viral DNA replication, the expression of the late 
transcription unit is dependent on the initiation of viral DNA replication and expression 
of the major late transcription unit (MLTU) (Thomas and Mathews, 1980). In human 
adenovirus (HAdV) -5, the MLTU generates a primary transcript that is processed into 
more than 20 different cytoplasmic mRNAs. These mRNAs are divided into five (L1–L5) 
families. Late transcriptional unit encode structural and non-structural proteins involved 
in the formation of progeny virions. 
The L4 region of the late transcription unit of HAdV-5 transcribes a spliced 
mRNA encoding 33K protein (Oosterom-Dragon and Anderson, 1983; Ostapchuk et al., 
2006). The 33K protein is expressed as a 39 kDa phosphoprotein and is predominantly 
localized in the nuclei of the infected cells (Gambke and Deppert, 1981; Oosterom-
Dragon and Anderson, 1983). Adenovirus 33K protein acts as an alternative RNA 
splicing factor (Tormanen et al., 2006), a transcriptional activator (Ali et al., 2007) and  
plays a role in viral capsid assembly / efficient capsid DNA interaction (Fessler and 
Young, 1999; Finnen et al., 2001; Kulshreshtha et al., 2004). Recently, adenovirus 22K 
protein has been shown to be involved in the packaging of adenovirus genome 
(Ostapchuk et al., 2006). 
Homologs of 33K protein have been identified in other Mastadenoviruses 
including bovine adenovirus (BAdV) -3 (Kulshreshtha et al., 2004; Ali et al., 2007). The 
L6 region of BAdV-3 transcribes a spliced mRNA encoding 33K protein, which is 
localized to the nucleus of virus infected cells (Chapter 3). Preliminary study suggested 
that 33K may be involved in virus assembly (Kulshreshtha et al., 2004). The conservation 
of 33K protein in Mastadenoviruses together with its multiple functions in the adenovirus 
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life cycle suggests that 33K protein might be involved in the interaction with other viral 
or cellular proteins. Earlier, we reported that the 33K protein appears to be interacting 
with protein V and 100K protein (Chapter 4). In this study, we demonstrate that 33K 
protein of BAdV-3 appears to interact with bovine presenilin-1-associated protein 
(BoPSAP). 
 
5.2 Materials and methods 
5.2.1 Cell lines  
Madin-Darby bovine kidney (MDBK) cells were cultured in minimal essential 
medium (MEM) with 10% fetal bovine serum (FBS). The wild-type BAdV-3 was 
cultivated in MDBK cells as described previously (Kulshrestha et al., 2004). VIDO R2 
(Reddy et al., 1999), a transformed fetal bovine retina cell (FBRC) line expressing the E1 
proteins of human adenovirus (HAdV)-5, and 293 cells (Graham et al., 1977) were grown 
in Eagle’s minimum essential medium containing 5-10% fetal bovine serum cells. HeLa 
cells were cultivated in MEM -medium containing 10% fetal bovine serum. 
 
5.2.2 Yeast and media 
 Matchmaker GAL4 two-hybrid system 3 and Yeast strain AH109 were obtained 
from Clontech. The pGADT7 vector containing bovine retina cDNA library was obtained 
from Wolfgang Baehr laboratory (University of Utah).  
  
5.2.3 Yeast two hybrid analysis 
 The AH109 yeast strain was inoculated into 10 ml of Yeast peptone dextrose 
adenine hemisulphate (YPDA) media containing 2% dextrose and grown at 30°C 
overnight. The 5 ml of overnight culture was transferred to 100 ml of warm YPDA 
medium and grown at 30°C till the OD600 reached 0.5±0.1. The cells were harvested by 
centrifugation at 1500 rpm for 5 minutes. The pellet was washed with 50 ml of sterile 
water and resuspended in 1XTE/LiAc buffer. The cells were aliquot into 100ul in each of 
the 1.5ml of centrifuge tubes. The transformation mixture consisting of 240 µl of 
polyethylene glycol, 36 µl of 1.0 M LiAc, 50 µl of predenatured salmon sperm DNA (2.0 
mg/ml), 5 µg of bovine retina cDNA library (library titer: 2 x 106 cfu/ml) , and 5 µg of 
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bait (pGB.33K) DNA (Chapter 4) was added to each of these tubes. The tubes were 
vortexed vigorously and incubated at 30°C for 30 minutes with shaking at 200 rpm and 
heat-shocked at 42°C for 15 minutes. The cells were pelleted, resuspended in 1X TE and 
spread on synthetic dropout medium plates containing 2% dextrose but lacking leucine 
and tryptophan. After six days incubation at 300C, the grown up colonies were transferred 
to the medium stringency media (synthetic dropout media plates lacking tryptophan, 
leucine and histidine) plates having 2% dextrose and later on transferred to the higher 
stringency media (synthetic dropout medium plates lacking tryptophan, leucine, histidine 
and adenine) plates having 2% dextrose and X- -gal. Blue colonies indicating positive 
clones were observed after 5-6 days of incubation. 
  Plasmid DNA was isolated from each of the blue colonies, transformed in DH5α 
cells and plated on LB-ampicillin selection media. The plasmid DNA from each clone 
was again isolated, grouped on the basis of restriction enzyme analysis. The 
representative plasmid DNA selected from each group was sequenced. The DNA 
sequence obtained was compared with sequences in the GenBank data base to identify 
the potential cellular genes interacting with 33K protein of BAdV-3. 
 
5.2.4 Isolation of bovine presenilin-1-associated protein and bovine microtubule 
associated protein ORFs 
 RNA was extracted from VIDO R2 (Reddy et al., 1999) cells using RNeasy kit 
(Qiagen). The first strand cDNA was synthesized using superscript II reverse 
transcriptase and oligo (dT) primers (Invitrogen). The cDNA (containing bovine 
presenilin-1-associated protein [BoPSAP] ORF) was amplified by PCR using  primers 
BoP1: 5’- GGAATTCCATATG ATGGCGGGAGCCGGAGCTG-3’; BoP2: 5’-GGAAT 
TCTTACT CCAGGGCAAAG CATGAT -3’. The PCR product was cloned into SmaI 
digested plasmid pGEX-5X-1 (Pharmacia) creating plasmid pGEX.BoPSAP. The 
plasmid DNA was used to determine the DNA sequence of the amplified PCR product. 
Similarly, a cDNA (containing a C-terminal bovine microtubule associated 
protein [BoMAP] ORF) was amplified by PCR using primers BoM1: 5’-GGA 
ATTCCATATG ATGATA TCCTTATATGCCTCACTCAC-3’; BoM2: 5’-GGAATTCT 
TACAGTTCGA TCTTGC ATGCA -3’. The PCR product was cloned into SmaI digested 
 88
plasmid pGEX-5X-1 creating plasmid pGEX.BoMAP.  
5.2.5 Plasmid construction 
Construction of plasmids pGEX.33K (Chapter 4.2.3), pC.33K (Chapter 3.2.3), 
OCT-CFP and OCT-Red (Harder et al., 2004) has been described earlier. 
 
         5.2.5.1 Construction of yeast expression plasmids  
                  A 1.1 kb fragment amplified by PCR using primers BoP1 and BoP2 (5.3.2) 
and plasmid pGEX.BoPSAP as a DNA template  was  digested with NdeI-EcoRI  and 
ligated to NdeI-EcoRI digested plasmid pGADT7 (Clontech) creating  plasmid 
pGA.BoPSAP (containing  full length BoPSAP ORF [354 amino acids]). Similarly, a 2.1 
kb fragment amplified by PCR using primers BoM1 and BoM2 (5.3.2) and plasmid 
pGEX.BoMAP as a DNA template.  The PCR product was digested with EcoRI enzyme 
and ligated to EcoRI digested plasmid pGADT7 (Clontech) creating plasmid 
pGA.BoMAP (containing full length BoMAP ORF [719 amino acid]). This cloning 
approach creates inframe HA epitope tag at 5’ end of BoPSAP and BoMAP.  
 
       5.2.5.2 Construction of plasmid pCF.V.  
      A 1.2 kb fragment containing BAdV-3 pV ORF (without stop codon) was 
amplified by PCR using the primers 5’-GGGGTACCATGGCCTCCTC TCGGTTG-3’ 
and 5’-CGGGATCCGGGTGATAGCG CACGCC-3’ and plasmid pGA.pV DNA 
(Chapter 4.2.3).  The PCR product was digested with KpnI-BamHI and ligated to KpnI-
BamHI digested plasmid OCT-CFP (cyano-fluorescent protein expression vector;-Harder 
et al., 2004) creating the plasmid pCF.V.  
 
       5.2.5.3 Construction of plasmid pCF.BoPSAP  
      The BoPSAP ORF without stop codon was amplified by PCR using the 
primers Bo3: 5’-GGGGTACCATGGCGGGAGCCGGAGCT-3’ and Bo4: 5’- GAAGAT 
CTCTCC A GGGCAA AGCATGATC-3’ and plasmid pGA.BoPSAP DNA as a template. 
The PCR product (containing BoPSAP ORF) was digested with KpnI-BglII and ligated to 
KpnI-BamHI digested plasmid OCT-CFP (cyano-fluorescent protein expression vector; 
Harder et al., 2004) creating plasmid pCF.BoPSAP. 
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  5.2.5.4 Construction of plasmid pDsRed.BoPSAP  
 The BoPSAP ORF without stop codon was amplified by PCR using the primers 
Bo3: 5’-GGGGTACCATGGCGGGAGCCGGAGCT-3’ and Bo4: 5’- GAAGAT 
CTCTCCAGGGCAA AGCATGATC-3’ and plasmid pGA.BoPSAP DNA as a template. 
The PCR product (containing BoPSAP ORF) was digested with KpnI-BglII and ligated to 
KpnI-BamHI digested plasmid OCT-DsRed (DsRed expression vector; Harder et al., 
2004) creating plasmid pDsRed.BoPSAP. 
 
5.2.6 GST pulldown assay 
The GST alone or GST-33K fusion protein (Chapter 4) were induced by 
isopropyl-β-D-thiogalactopyranoside (IPTG) (Gibco-BRL) and immobilized on 
Glutathione-Sepharose beads (Pharmacia) as described elsewhere (Zhou and Tikoo, 
2001).  
Individual plasmid (pGA.BoPSAP, pGA.BoMAP, pGADT7) DNA was in vitro 
transcribed and translated using TNT T7 quick-coupled Transcription/Translation kit 
(Promega) in the presence of 30 μCi of [35S] methionine. A 5ul of in vitro translated  
protein was added individually to beads bound 10 ug of GST or GST-33K fusion protein 
in 500ul of binding buffer (30mM Hepes pH 7.4, 50mM KCL, 0.5% Tween 20, 0.5% 
nonfat dry milk, 2mM PMSF) and incubated at 4°C for 4 hrs with rotation. The beads 
were then washed four times with the binding buffer. The bead bound proteins were 
separated by sodium dodecyl sulphate (SDS) - polyacrylamide gel electrophoresis 
(PAGE) and analyzed by autoradiography. 
 
5.2.7 Confocal microscopy 
 HeLa cells plated on Lab-Tek II chamber slide (Nunc) were co-transfected with 
individual plasmid DNAs.  Forty eight hrs post-transfection, the cells were fixed in 4% 
paraformaldehyde for 15 min at room temperature, washed four times with PBS and 
permeabilized with ice cold acetone for 5 min. The cells were then rinsed with PBS three 
times and mounted in DABCO mounting media (Fluka). Finally, the cells were analyzed 
by confocal microscopy using laser scanning microscope. 
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5.2.8. Apoptosis assay. 
     293 cells were transfected with individual plasmid DNA (pCDNA or pC.33K). 
After 48 hrs, the transfected or non transfected cells were treated with 1μm Stauroprorine. 
After 4 hrs of staurosporine treatment, the cells were treated with 0.25 % trypsin EDTA 
for 5 min at 370C. The detached cells were collected, washed three times with cold PBS 
and annexin binding buffer. Cells were later treated with FITC-annexin V and propidium 
iodide at room temperature for 15 minutes. Following the incubation period, annexin 
binding buffer was added to the cells and the stained cells were analyzed by flow 
cytometry. The annexin-V/propidium iodide (PI) assay indicates the percentage of cells 
undergone early and late apoptosis.  The annexin V has a strong affinity to bind to phosp 
-hatidylserine exposed on the surface of the membrane of the cell during apoptosis. 
To identify the cleavage of poly (ADP-ribose) polymerase (PARP), the cells were 
transfected with individual plasmid DNAs (pCDNA or pC.33K). After 48 hrs of 
transfection, the transfected or non transfected cells were treated with staurosporine. 
After 4 hrs of treatment, the cells were lysed and analysed by Western blot analysis as 
described (Chapter 4) using monoclonal antibody against PARP (BD PharMingen). 
 
5.3. Results 
  5.3.1 Screening of bovine retina cDNA library  
 To identify the cellular proteins interacting with 33K protein, the bovine retina 
cDNA library cloned in plasmid pGADT7 (Clontech) was screened using 33K protein as 
a bait in yeast two-hybrid system. The screening of cDNA library was made stringent by 
selecting the interacting proteins by growing cotransformants on SD/Leu-Trp-His- plates 
(medium stringency) followed by SD/Leu-Trp-His-Ade- plates (high stringency) 
containing X-α-gal. The Ade provides a strong nutritional selection, HIS3 reduces the 
incidence of false positive and MEL1 or LacZ encoding β-galactosidase can be assayed 
on X-α-gal indicator plates. Out of 2 x 106 clones screened, 150 clones showed bluish 
colonies (Fig. 5.1) suggesting some positive interactions. The plasmid DNAs isolated 
from these yeast clones was used to transform DH5α cells. Since bovine cDNA library 
was constructed using EcoRI site of plasmid pGADT7 (Zhang et al., 2004), the plasmid  
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Fig. 5.1.  Yeast cDNA library screening.  Plasmid pGAD7 (prey) containing cDNA 
library of bovine retina cells and plasmid pGB.33K were co transformed in yeast AH109 
cells. Similarly, plasmid pGADT7 and plasmid pGB.33K were co transformed in yeast 
AH109 cells.The co-transformants were streaked on SD/Leu-/Trp-/His-/Ade-/ X-α-gal-
containing plates and incubated at 30°C for 5-7 days.  
 
 
pGA.BoPSAP 
pGA.BoMAP 
 
pGADT7 
pGADT7 
pGB. 33K
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DNAs isolated from ampicillin resistant DH5α bacteria were digested by EcoRI and 
observed for the release of insert(s). Based on the size of the released DNA inserts 
plasmid DNAs were grouped into 30 groups. The DNA sequence of an insert DNA from 
each group was determined. Analysis of the DNA sequences of different inserts showed 
significant homology to Homo sapiens Presenilin-1-associated protein (HuPSAP; 
GenBank Accession # AF189289) and Homo sapiens Microtubule associated protein 
(HuMAP GenBank Accession # NM 005909) . 
 
5.3.2 Identification of BoPSAP and BoMAP ORFs 
RT PCR analysis of RNA (isolated from VIDO R2 cells) using primers BoP1 / 
BoP2 amplified two fragments of 1.1kb and 700 bp (Fig. 5.2A). Similarly, RT PCR 
analysis of RNA (isolated from VIDO R2 cells) using primers BoM1 / BoM2 amplified a 
fragment of 2.1kb (Fig. 5.2B). The 1.1kb and 2.1kb PCR fragments were individually 
clones in SmaI digested plasmid pGEX-5X-1 to create plasmid pGEX.BoPSAP and 
plasmid pGEX.BoMAP, respectively. 
 The DNA sequence of plasmid pGEX.BoPSAP containing 1.1kb PCR fragment, 
identified an ORF of 1062 nucleotides encoding a protein of 354 amino acids (Fig 5.3A) 
with a predicted molecular weight of 38 kDa. The protein designated as BoPSAP 
(Fig.5.3A) contains an N-terminal signal sequence of 19 amino acids and a potential 
transmembrane anchor of 23 amino acids. The predicted translation product contains a 
mitochondrial carrier protein sequence (Lamarca et al., 2007) from amino acid 206 to 
266. The BoPSAP showed 98% homology with HuPSAP (Xu et al., 2002). Moreover, 
apoptotic domain identified in HuPSAP (Lamarca et al., 2007) is conserved in BoPSAP  
(amino acid 65 to 168). 
The DNA sequence of plasmid pGEX.BoMAP containing 2.1kb PCR fragment 
identified an ORF of 2157 nucleotides encoding a protein of 719 amino acids (Fig. 5.3B) 
with a predicted molecular weight of 79 kDa. The protein designated as BoMAP showed 
87% homology with HuMAP (Lien et al., 1994). 
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Fig. 5.2. RT-PCR .  Total RNA isolated from VIDOR2 cells was reverse transcribed 
using Oligo (dT) as primer. The BoPSAP specific cDNA (A) or BoMAP specific cDNA 
(B) were amplified by PCR using primers BoP1/BoP2 and BoM1/BoM2 respectively. 
The amplified products were analyzed on a 1 % agarose. 
BoMAP 
BoPSAP
  M                  1            2
M           1                 2
2.1kb 
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(A) 
 
MAGAGAGAGA RGGAAAGVEA RARDPPPAHR AHPRHPRPAA QPSARRMDGA  50 
SGGLGSGDNA PTTEALFVAL GAGVTALSHP LLYVKLLIQV GHEPMPPTIG 100 
TNVLGRKVLY LPSFFTYAKY IVQVDGKIGL FRGLSPRLMS NALSTVTRGS 150 
MKKVFPPDEI EQVSNKDDMK TSLRKVVKVT SYEMMMQCVS RMLAHPLHVI 200 
SMRCMVQFVG REAKYSGVLS SIGKIFKEEG LLGFFVGLIP HLLGDVVFLW 250 
GCNLLAHFIN AYLVDDSFSQ ALAIRSYTKF VMGIAVSMLT YPFLLVGDLM 300 
AVNNCGLQAE LPPYSPVFKS WIHCWKYLSV QGQLFRGSSL LFRRVSSGSC 350 
FALE            354 
 
(B) 
 
MISLYASLTS EKVQSLDAEK LSPKSDISPL TPRESSPLYS PSLSDSTSAV  50 
KDSTAACHTA SPPPMDAASA EPYGFRASML FDTMPHHLAL NRDLTTPGME 100 
EDTGGKTPGD FSYAYEKPET TTRSPDEEGY DYEAYEKTTR TPDVSGYYYE 150 
KTESVTKSPC DSSYSYETME KTSKSPEDGG YAYEITEKTT RSPEESGYAY 200 
EISEKTIRTP EVSAYSYEKA ERSRRLLDDI SNGYDDSEEG GHTLGDSSYS 250 
YETTEKTAGF PESESYSYET STTTTRSPDA SAYCYETPEK ITRAPQVSSY 300 
AYETSDQCYT AEKKSPSEAR QDVDLCLVSS CEYKHPKTEL SPSFINPNPL 350 
EWFASEEPTE ESEKPLTQSG GAPPPPGGKP QGRQCDETPP TSVSESAPSQ 400 
TDSDVPPETE ECPSITADAN IDSEDESETI PTDKTVTYKH MDPPPAPMQD 450 
RSPSPRHPDV SMMDPEALAI EQNLGKALKK DLKEKTKTKK PGTKTKSSSP 500 
VKKGDGKSKP SAASPKPGAL KESSDKVSKV ASPKKKESVE KATKTTTTPE 550 
VKAARGEEKD KETKNAANAS TSKSVKTATA GPGTTKTSKP SAVPPGPPVY 600 
LDLCYIPNHS NSKNVDVEFF KRVRSSYYVV SGNDPAAEEP SRAVLDALLE 650 
GKAQWGSNMQ VTLIPTHDSE VMREWYQETH EKQQDLNIMV LASSSTVVMQ 700 
DESFPACKIE L                                           711 
 
Fig. 5.3. Deduced amino acid sequence of cellular genes A) Amino acid sequences of 
Bovine Presenilin-1-associated protein (BoPSAP): Underlined residues indicate apoptotic 
domain (solid line), mitochondria carrier homology domain (double solid lines) and 
transmembrane domains (wavy solid line).  B) Amino acid sequence of Bovine 
Microtubule Associated protein (BoMAP). 
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 5.3.3 Yeast two hybrid assay 
 Since the BoPSAP DNA and BoMAP DNA inserts identified by cDNA library 
screening appeared truncated, we repeated the yeast two hybrid analysis using full length 
BoPSAP and BoMAP genes. To achieve this, we constructed  plasmid pGA.BoPSAP  
(containing  full length BoPSAP ORF [354 amino acids]) and plasmid pGA.BoMAP 
(containing C-terminal BoMAP ORF [ 719 amino acid])  amplified  by RT-PCR of 
mRNA isolated from  VIDOR2 cells (Reddy et al., 1999). The yeast strain AH109 was 
cotransformed with bait and prey plasmids and the interactions were screened though 
different selection stringencies as described earlier (Singh et al., 2005). The higher 
stringency selection revealed the appearance of blue colonies upon co-transforming 
plasmid pGB.33K DNA along with plasmid pGA.BoPSAP DNA or plasmid 
pGA.BoMAP DNA (Fig 5.4). No such blue colonies were observed on co-transforming 
plasmid pGB.33K DNA and plasmid pGADT7 DNA in the yeast (Fig. 5.4). These 
findings suggest that 33K protein may be specifically interacting with BoPSAP and 
BoMAP. 
 
5.3.4 GST-pulldown assay 
To confirm the results of yeast two hybrid analyses, we tested the interaction of 
proteins in-vitro using GST pull down assay. The GST alone or GST-33K fusion protein 
(Chapter 4) were induced by IPTG and the expression of these proteins were confirmed 
by Western blot using anti-GST and anti-33Kp serum respectively (Fig. 5.5). The 
induced GST and GST-33K fusion proteins were bound on glutathione sepharose beads 
as described earlier (Zhou and Tikoo, 2001). Since T7 promoter is located 5’ to BoPSAP 
or BoMAP coding sequence in the plasmid pGA.BoPSAP and plasmid pGA.BoMAP 
respectively, these plasmids were used to transcribe and translate these proteins in- vitro 
in the presence of 50 μl of [35S] methionine, using TNT T7-coupled reticulocyte lysate 
system as described by the manufacturer (Promega). The GST or GST-33K proteins 
bound to glutathione sepharose beads were individually incubated with in-vitro translated 
[35S]-labeled proteins for 6 h at 4oC. After extensive washing with binding buffer, the 
bead bound products were separated on 10% SDS-PAGE and visualized by 
autoradiography. 
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Fig. 5.4 Yeast two-hybrid analysis. Plasmid pGA.BoPSAP DNA or plasmid 
pGA.BoMAP DNA was individually  co-transformed with plasmid pGB.33K DNA in 
yeast strain AH109. Similarly, plasmid pGADT7 and plasmid pGB.33K were co 
transformed in yeast AH109 cells.The co-transformants were streaked on SD/Leu-/Trp-
/His-/Ade-/ X-α-gal-containing plates and incubated at 30°C for 5-7 days. pGBKT7 was 
used as negative control. 
 
pGB. 33K 
pGADT7 
pGA.BoPSAP 
pGA.BoMAP 
 
pGADT7 
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Fig. 5.5. Immunoblot analysis of Glutathione-Sepharose-immobilized proteins. 
Purified GST (lane 2) and GST-33K (lane 4) proteins were separated by 10% SDS–
PAGE, transferred to Immobilon-P membrane and analyzed by immunoblotting using 
anti-GST serum (lanes 1,2) and anti-33Kp serum (lane 3,4) . Uninfected cell lysates 
(lanes 1,3) were used as  negative controls. The position of the molecular weight markers 
(M) in kDa is shown to the left of the each panel. Arrows on the right of each panel 
indicate the position of the identified protein. 
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Fig. 5.6. GST pull down assay. (A) Purified GST (lane 1) or GST-33K (lane 2) proteins 
were immobilized on glutathione-Sepharose 4B beads, incubated with in vitro translated 
[35S] methionine-labeled BoPSAP  were sepatated by 10% SDS-PAGE and detected by 
autoradiography. Lane 3 indicates in vitro translated [35S] methionine labeled BoPSAP 
(B) Purified GST (lane 1) or GST-33K (lane 2) proteins were immobilized on 
glutathione-Sepharose 4B beads, incubated with in vitro translated [35S] methionine-
labeled BoMAP  were sepatated by 10% SDS-PAGE and detected by autoradiography. 
Lane 3 indicates in vitro translated [35S] methionine labeled BoMAP. The position of the 
molecular weight markers (M) in kDa is shown to the left of the each panel. Arrows on 
the right of each panel indicate the position of the identified protein. 
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As seen in Fig 5.6A, in vitro translated BoPSAP protein appears to interact with GST-
33K protein (lane 2) but not with GST protein (lane 1). No such interaction was detected 
between in vitro synthesized BoPSAP and GST protein alone (lane 1) demonstrating the 
specificity of the assay. These results confirm the yeast two hybrid observations, and 
further suggest that 33K-BoPSAP interaction is real. In contrast BoMAP protein 
appeared to interact with GST (Fig. 5.6B, lane 1) as well as with GST-33K (Fig. 5.6B, 
lane 2). These results suggested that in vitro translated BoMAP interacted specifically 
with GST protein. These results suggest that interaction detected using Yeast two hybrid 
system may not be real. 
 
5.3.5 BoPSAP localizes to mitochondria   
Since the human homolog of BoPSAP localizes to mitochondria (Xu et al., 2002), 
we determined if BoPSAP also localizes to the mitochondria. Hela cells in Lab-Tek II 
chamber slide (Nunc)  were co-transfected with 0.5 μg/well plasmid pCF.BoPSAP DNA 
and 0.5 μg/well plasmid OCT-DsRed (mitochondrial marker OCT [ornithine carbamyl  
transferase] pre-sequence fused to DsRed2) DNA  (Harder et al., 2004), or plasmid OCT-
DsRed DNA 0.5 μg/well and 0.5 μg/well plasmid pCF.V  DNA.  Forty eight hrs post-
transfection, the cells were analyzed by confocal microscopy. As expected, sub cellular 
distribution of OCT-DsRed was consistent with the localization in mitochondria (Fig. 
5.7A). The CF.BoPSAP displayed the fluorescence throughout the cytoplasm of the 
transfected cells with no diffuse staining (Fig. 5.7A). However the merging of two images 
showed purple region of colocalization (Fig. 5.7A). In contrast, CF.V displayed 
predominantly nuclear fluorescence (Fig. 5.7A) and does not appear to colocalize with 
OCT-DsRed (Fig 5.7A) in the mitochondria.  These results suggest that like HuPSAP, 
BoPSAP protein localizes to the mitochondria. 
 
5.3.6 33K also localizes to mitochondria 
The proteins execute their function when they are targeted to the sub-cellular 
compartments via specific localization signals. Analysis of 33K protein by MioProt 
program predicted the presence of a mitochondrial localization signal (N-terminus 38 
amino acids). To determine if 33K protein also localizes in the mitochondria, Hela cells 
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Fig. 5.7. Subcellular localization of proteins. (A)  BoPSAP protein. Monolayers of  
HeLa cells in four well Lab-Tek chamber slides were cotransfected individually with 
plasmid pCF.BoPSAP DNA (0.5μg/well and plasmid OCT-DsRed DNA (0.5 μg/well) or 
plasmid pCF.V DNA (0.5  g./well) and plasmid OCT-Red DNA (0.5 g/well) . After 48h 
post-transfection, the cells were visualized by confocal microscope. (B)  33K protein. 
Monolayers of  HeLa cells were cotransfected with plasmids pEY.33K DNA (0.5 
μg/well)  and  OCT-DsRed DNA (0.5 μg/well). At 48h post-transfection, the cells were 
visualized by confocal microscope. (C) 33K protein and BoPSAP. Monolayers of  HeLa 
cells were cotransfected individually with plasmids pEY.33K DNA (0.5 μg/well)  and  
pDsRed-BoPSAP DNA (0.5 μg/well). At 48h post-transfection, the cells were visualized 
by confocal microscope. 
 
CF.BoPSAP OCT-DsRed Merge 
CF.pV OCT-DsRed Merge 
EY.33K Merge OCT-DsRed 
EY.33K DsRed-BoPSAP Merge
(A)
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were co- transfected with the plasmid OCT–DsRed2 (ornithine carbamyl transferase pre-
sequence fused to DsRed2) (Harder et al., 2004) DNA and plasmids pEY.33K DNA. 
Forty eight hrs post transfection, the cells were fixed with 4% paraformaldehyde and 
examined by confocal microscopy. As seen in Fig. 5.7B, the EY.33K protein expressed in 
transfected cells was localized predominantly within the nucleus (Fig. 5.7B). However, a 
small amount of EY.33K protein was also detected in the mitochondria as it showed                     
co-localization with the mitochondrial localized OCT-DsRed2 protein (Fig.5.7B). 
 
5.3.7. Colocalization of 33K and BoPSAP in mitochondria.   
  To determine if 33K protein also localizes with BoPSAP in the mitochondria, 
Hela cells were co-transfected with 0.5 μg plasmid pDsRed-BoPSAP DNA and 0.5 
μg/well plasmid pEY.33K DNA. Forty eight hrs post transfection, the cells were fixed 
with 4% paraformaldehyde and examined by confocal microscopy. As seen in Fig. 5.7C, 
the EY.33K protein expressed in transfected cells was localized predominantly within the 
nucleus (Fig. 5.7C). However, a small amount of EY.33K protein was also detected in the 
mitochondria as it showed co-localization with the mitochondria localized DsRed-
BoPSAP protein (Fig. 5.7C).  
 
 5.3.8    33K protein induces anti-apoptotic activity 
Since the 33K protein is a late protein and a portion of 33K protein localizes to 
the mitochondria, we determined whether the 33K protein shows anti-apoptotic activity. 
The annexin V staining precedes the loss of integrity of cell membrane, which 
accompanies the latest stages of cell death resulting from either apoptosis or necrosis. 
Hence, the staining with annexin V along with PI (vital dye) helps in identifying early 
apoptotic cells. 
The 293 cells were transfected individually with plasmids pC.33K or  
pCDNA3 (as a negative control), followed by treatment with stauroporine (a caspase-
independent direct activator known to induce apoptosis in cells by blocking the activity 
of many kinases [Kabir et al., 2002]) for four hrs. After 48 hrs, the transfected cells were 
collected, washed twice with PBS and stained with annexin V and propidium iodide (PI). 
The annexin V/PI stained cells were analyzed by flow cytometry. As shown in Fig. 5.8, 
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compared to plasmid pcDNA3 DNA transfected cells, pC.33K transfected cells showed 
60% decrease in annexin V/PI positive cells. These results suggested that the 33K protein 
may have the potential to counteract the staurosporine induced apoptosis. 
The anti-apoptotic activity of 33K protein was further confirmed by cleavage of  
poly(ADP-ribose) polymerase (PARP).  Since the cleavage of the PARP (death substrate) 
is a hallmark for apoptosis (Dubrez et al., 1996; Bluethner et al., 2007), we analyzed the 
cleavage of PARP in plasmid DNA transfected cells. The 293 cells were transfected 
individually with plasmids pC.33K or pCDNA3 (as a negative control), followed by 
treatment with staurosporine. After 48 hrs, the cells were collected and analyzed by 
Western blot using anti-PARP serum. As seen in Fig 5.9A, B mock transfected cells 
treated with staurosporine showed 100 % of PARP cleaved to its 85 kDa form. Similarly, 
pCDNA3 transfected cells treated with staurosporine showed 80% of PARP cleaved to its 
85 kDa form (Fig. 5.9A, B). In contrast, pC.33K transfected cells treated with 
staurosporine showed only 20% of PARP cleaved to its 85 kDa (Fig. 5.9A, B). These 
experiments revealed that 33K protein may have the ability to counteract the 
stauropsorine induced apoptosis. 
5.4 Discussion 
The 33K protein of adenovirus appears to be a multifunctional protein, which acts as 
alternative splicing factor (Tormanen et al., 2006) and plays an important role in viral 
assembly (Fessler and Young, 1999; Finnen et al., 2001; Kulshreshtha et al., 2004), 
stimulation of transcription from the MLP (Farley et al., 2004; Ali et al., 2007) and early 
to late switch in MLP transcription (Farley et al., 2004). Here, we report for the first time 
that 33K protein interacts with the protein similar to presenilin-1-associated protein and 
may inhibit apoptosis. 
The screening of bovine retina cDNA library, using 33K as bait by yeast two hybrid 
analysis revealed that 33K protein may be interacting with bovine presenilin-1-associated 
protein (BoPSAP) and microtubule associated protein (BoMAP). This initial observation 
between 33K and BoPSAP is supported by the fact that these interactions were confirmed 
in vitro by GST pull down assay and colocalization assays. However, the interactions 
(observed by yeast two hybrid screening) between 33K protein and BoMAP were not 
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Fig. 5.8. Anti-apoptotic activity of 33K protein. 293 cells were cotransfected 
individually with plasmid pC.33K DNA, or  pCDNA3 DNA. At 48h post-transfection, 
the cells were treated with 1μM concentration of staurosporine for 4 hrs. Finally, the cells 
were trypsized, washed and stained with annexin V / propidium iodide (PI). The Annexin 
V/PI stained cells were analyzed by flow cytometry. 
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Fig. 5.9. PARP cleavage assay. (A) 293 cells were transfected with indicated plasmid 
DNA. After 48 hrs, the transfected cells were treated with 1μm staurosporine (Sigma 
S6942). After 4hrs of treatment, proteins from lysates of cells were separated by 10% 
SDS-PAGE under reducing conditions, transferred to nitrocellulose membranes and 
analyzed by Western blotting using anti-actin serum (Sigma) or monoclonal antibody 
against PARP (BD PharMingen). The position of specific bands is shown to the right of 
the panels. (B) Graphic representation of the results described in A. SDs were calculated 
from three independent experiments. 
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confirmed by GST pulldown assay suggesting that 33K-BoMAP interaction was a false 
observation.  
The detection of specific interaction between 33K and BoPSAP suggested that such 
interactions have a significant role in the virus life cycle. However, the exact function of 
these interactions during the viral infection is currently unclear. The HuPSAP protein a 
human homolog of BoPSAP has been shown to induce apoptosis when over expressed in 
the cells (Xu et al., 2002; Lamarca et al., 2007). Since BoPSAP shows significant 
homology to HuPSAP there is a possibility that BoPSAP may also be involved in 
inducing apoptosis. In fact, BoPSAP contain domains, which show complete homology 
to domains of HuPSAP involved in inducing apoptosis (Lamarca et al., 2007).  
Mitochondria is an important organelle involved in regulating the apoptosis cascade 
(Han et al., 2006; Feng et al., 2008). To counter the effect of apoptosis, viruses encode 
mitochondria localized proteins, which can inhibit apoptosis (Hart et al., 2007; Radke et 
al., 2008). Several evidence suggests that BAdV-3 33K proteins may act as anti-apoptotic 
protein. First, confocal studies revealed that in addition to nucleus, a portion of 33K 
localizes to the mitochondria. Secondly, BAdV-3 33K colocalizes with BoPSAP in 
mitochondria. Thirdly, expression of 33K significantly reduced the presence of apoptotic 
cells in Staurosporine treated cells. Finally, 33K significantly reduced the cleavage of 
PARP.  
Thus, the interaction of 33K with BoPSAP may inactivate BoPSAP and induce an 
anti-apoptotic effect. This property of 33K protein may help in successful propagation of 
BAdV-3 by overcoming apoptosis, a part of innate and acquired immune responses (Jung 
et al., 2004; Cardoso et al., 2008). Further studies are in progress to identify the domain 
of 33K protein involved in interaction with BoPSAP protein. 
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6.0 GENERAL DISCUSSION AND CONCLUSION 
 
To date, all reported members of Mastadenovirus genus contain homologs of 22K 
ORF and 33K ORF originating from an unspliced and a spliced form of a late transcript, 
respectively. Recent reports indicate that 33K acts as an alternative RNA splicing factor 
(Tormanen et al., 2006) and a transcriptional activator (Ali et al., 2007), and plays a role 
in viral capsid assembly as well as efficient capsid DNA interaction (Fessler and Young, 
1999; Finnen et al., 2001; Kulshreshtha et al, 2004). Recently, adenovirus 22K protein 
has been shown to be involved in the packaging of adenovirus genome (Ostapchuk et al, 
2006). Based on the nucleotide sequence of genomic DNA, similar genomic organization 
has been proposed for BAdV-3 (Kulshreshtha et al., 2004).  However, our earlier data 
about structural and functional study could not resolve the issue of the existence of   both 
33K protein and 22K protein in BAdV-3 infected cells (Kulshreshtha et al., 2004).   
Thus, the primary objective of this investigation was to further characterize 33K 
protein, determine its role in BAdV-3 infection and elucidate its interaction (if any) with 
other viral /cellular proteins. 
Using RT-PCR analysis, we also detected spliced and unsliced mRNAs encoding 33K 
and 22K proteins, respectively in BAdV-3 infected cells. This was confirmed using rabbit 
polyclonal antisera raised against peptides representing unique C- terminal regions of the 
proteins. Anti-33Kp serum detected five major proteins of 42 kDa, 39 kDa, 37 kDa, 21 
kDa and 19 kDa and three minor proteins of 35 kDa, 25 kDa, and 23 kDa in BAdV-3 
infected cells or 33K transfected cells. The 21 kDa band appears to be a doublet. 
Similarly, anti-22Kp serum detected three proteins of  41kDa, 39kDa and 37kDa in  
BAdV-3 infected cells. However, only two proteins of 39kDa and 37kDa were detected 
in 22K (having splice sites removed) transfected cells. The 33K protein is predominantly 
localized to the nucleus of BAdV-3 infected cells and is involved in stimulating the 
transcription from major late promoter. Analysis of mutant 33K proteins demonstrated 
that amino acids 201-240 and amino acid 213-232 are required for nuclear localization 
and MLP transactivation, respectively.  
Since the assembly of mature adenovirus is a multi-step process involving protein-
protein (homotypic / heterotypic) and protein-DNA interactions, the involvement of 33K 
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in various steps of adenovirus replication and assembly may require the direct protein-
protein interactions. Earlier, reports have demonstrated protein –protein interactions 
among several adenovirus proteins in virus infected cells (Ewing et al., 2007; Ostapchuk 
and Hearing, 2008; Perez-Romero et al., 2005; Singh et al., 2005). As adenovirus 33K 
protein appears to be a multifunctional protein performing different roles in viral 
infection, the involvement of 33K protein in different steps of adenovirus replication may 
require protein-protein interaction. Thus, the next step was to determine if 33K protein 
interacts with other BAdV-3 proteins.  
Using 33K proteins a bait in the yeast two hybrid system, we screened open reading 
frames (ORFs) of bovine adenovirus (BAdV)-3 for potential interactions with 33K 
protein. Interestingly, 33K protein showed specific interaction with 100K and pV 
proteins. The yeast two-hybrid findings were validated by in vitro binding using in vitro 
synthesized transcription-translation products, GST-pull down assay and in vitro co-
immunoprecipitation assay using protein-specific antibodies. We demonstrated, that the 
interaction of 33K protein with 100K and pV proteins take place during BAdV-3 
infection. Finally, our data suggests that the stretch of amino acids 81-120 and 161-200 in 
33K protein are critical for the interaction with pV and 100K proteins, respectively. 
The existence of such interactions in other adenoviruses and exploring the functional 
consequences of these interactions will help in determining the importance of such 
interactions. 
A number of adenoviral proteins have been shown to interact with other cellular 
proteins during different stages of viral replication (Green et al., 2008; Xue et al., 2005; 
Yondola and Hearing, 2007). These interactions may alter the activities of cellular 
regulators of gene expression (Miura et al., 2007), cell cycling (Berk et al., 2005; Seifried 
et al., 2008) and apoptosis (Seifried et al., 2008). In addition, these interactions may help 
in sequestering (Fleisig et al., 2007) or redistribution (Yondola and Hearing, 2007) of 
important cellular proteins thus helping to defend against antiviral cellular responses 
(Weitzman and Ornelles, 2005). At different stage of virus replication, different 
adenovirus protein may be involved, in interacting with the same cellular protein(s) or 
altering the same cellular process (Berk, 2005) suggesting that adenovirus proteins are 
functionally redundant. Based on these reports, it is clear that these interactions are 
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critical for setting up the host for efficient adenovirus production during a lytic cycle 
(Weitzman and Ornelles, 2005).  
Using bovine retina cDNA library, we demonstrated that BAdV-3 33K protein 
appeared to interact with bovine presenilin-1-associated protein / mitochondrial carrier 
homolog 1 (BoPSAP / BoMtch1) and bovine microtubule associated protein (BoMAP). 
However, subsequent analysis by various in vitro and in vivo assays could only confirm 
the interaction between 33K protein and BoPSAP/BoMtch1.  False positive results can be 
detected using yeast two hybrid systems. As such yeast two hybrid results should always 
be confirmed using different in vitro and in vivo assays. 
Human presenilin-1-associated protein / mitochondrial carrier homolog 1 (hPSAP / 
Mtch1) is a pro apoptotic outer mitochondrial protein (Lamarca et al., 2007; Xu et al., 
2002). Two isoforms of hPSAP / Mtch1 have been identified (Lamarca et al., 2007) in 
human tissues, which share two pro apoptotic domains and multiple internal signals for 
import into the mitochondrial outer membrane (Lamarca et al., 2007). Human PSAP 
protein induces apoptosis when over expressed in cells in culture (Lamarca et al., 2007; 
Xu et al., 2002), However, we could isolate and identify only one form of BoPSAP 
protein from bovine cells. Our results suggest that 33K protein co-localizes with BoPSAP 
in the mitochondria and can modulate the apoptotic effect of Stauroporine. Further 
experiments are in progress to determine if BoPSAP can induce apoptosis in cells and the 
role 33K can play in modulating the pro apoptotic effect of BoPSAP. 
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